Abstract is: Peritoneal carcinomatosis (PC) is intraperitoneal dissemination (carcinosis) of any form of cancer that does not originate from the peritoneum itself. PC is most commonly seen in abdominopelvic malignancies. Computed tomography (CT) is particularly important for detailed preoperative assessment and evaluation of the radiological Peritoneal Cancer Index (PCI). * Cytopathology of peritoneal fluid (Pap stain) in a case of peritoneal carcinomatosis, showing typical features of adenocarcinoma.
| P2671 | Google Knowledge Graph ID | /g/11hbqc134t |
| P6366 | Microsoft Academic ID | 2908869751 |
| P1748 | NCI Thesaurus ID | C27382 |
| P10283 | OpenAlex ID | C2991818862 |
| P4233 | PatientsLikeMe condition ID | peritoneal-metastases |
| P2892 | UMLS CUI | C0346990 |
| P1995 | health specialty | oncology | Q162555 |
| Q44156602 | "Straight line" sign of diffuse peritoneal carcinomatosis on sagittal FDG positron emission tomographic images |
| Q52984731 | (18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study. |
| Q46104163 | (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q35155742 | (18)F-Fluorine-18-l-dihydroxyphenylalanine ((18)F-DOPA) positive isolated peritoneal carcinomatosis from a MENII-related medullary thyroid carcinoma. About an atypical metastatic site and utility of (18)F-FDOPA. |
| Q39632700 | 177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi |
| Q55041329 | 2017 Update on Ovarian Cancer Peritoneal Carcinomatosis Multimodal-Treatment Considerations. |
| Q95377014 | 5-Aminolevulinic Acid Fluorescence in Detection of Peritoneal Metastases |
| Q43183621 | 5-Aminolevulinic-acid-mediated Photodynamic Diagnosis Enhances the Detection of Peritoneal Metastases in Biliary Tract Cancer in Mice. |
| Q46470030 | 5-FU uptake in peritoneal metastases after pretreatment with radioimmunotherapy or vasoconstriction: an autoradiographic study in the rat. |
| Q33647418 | 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice |
| Q46004708 | 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. |
| Q100528491 | 68Ga FAPI PET/CT Imaging in Peritoneal Carcinomatosis |
| Q43941230 | 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer |
| Q74575871 | A 5-year survivor after resection of peritoneal metastases from pedunculated-type hepatocellular carcinoma |
| Q97522101 | A Burning External Colon Cancer Patient With Diffuse Miliary Peritoneal Metastases |
| Q40846479 | A Case of Ovarian Carcinoma with Peritoneal Metastases, treated by Transfusion of Maternal Blood and Injections of Radiated Ascitic Fluid |
| Q39255140 | A Perioperative Clinical Pathway Can Dramatically Reduce Failure-to-rescue Rates After Cytoreductive Surgery for Peritoneal Carcinomatosis: A Retrospective Study of 666 Consecutive Cytoreductions |
| Q33418461 | A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosis |
| Q35661054 | A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis |
| Q48036426 | A Rare Cause of Bowel Obstruction: Peritoneal Metastases in Osteosarcoma at the Tibia in a Young Female Patient with Brain Metastasis. Case Report |
| Q60629606 | A Simple Tumor Load-Based Nomogram for Surgery in Patients with Colorectal Liver and Peritoneal Metastases |
| Q38836835 | A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC. |
| Q46479492 | A case of Stage IV gastric cancer with liver and peritoneal metastases responding completely to tailored S-1/CPT- 11 combination therapy |
| Q53653636 | A case of advanced gastric cancer with peritoneal metastases responding to bi-weekly paclitaxel therapy |
| Q72862782 | A case of antidiuretic hormone, oxytocin and clacitonin producing oat cell carcinoma of the lung with prominent peritoneal carcinomatosis (author's transl) |
| Q36796676 | A case of disseminated carcinomatosis of the bone marrow originating from gastric cancer 3 years after intraperitoneal chemotherapy against peritoneal carcinomatosis |
| Q46800016 | A case of multiple hepatic and peritoneal metastases from colon cancer responding to oral UFT+leucovorin chemotherapy |
| Q39270155 | A case of pain management using transdermal fentanyl patches for peritoneal carcinomatosis in a patient with small intestine stoma |
| Q45127221 | A case of rectal cancer with multiple liver and peritoneal metastases that responded dramatically to low-dose 5-FU plus LV and CDDP combination chemotherapy |
| Q45156128 | A case of scirrhous carcinoma of the stomach with malignant pleural and peritoneal carcinomatosis responding to the local administration of docetaxel (TXT) |
| Q46295658 | A case of stomach cancer with calcifications in peritoneal metastases and osteoid tissue production |
| Q33746167 | A case of unsuspected peritoneal mesothelioma occurring with colonic adenocarcinoma masquerading as peritoneal metastases |
| Q37223186 | A case report of Hepatoid Carcinoma of the Ovary with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy without systemic adjuvant therapy |
| Q36918671 | A case report of symptomatic gallbladder disease in the setting of peritoneal carcinomatosis originating from invasive lobular carcinoma of the breast |
| Q83194006 | A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin |
| Q42609788 | A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats. |
| Q38829910 | A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent |
| Q84567602 | A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis |
| Q36363288 | A curative approach to peritoneal carcinomatosis from colorectal cancer |
| Q87711771 | A feasibility study of the use of computed virtual chromoendoscopy for laparoscopic evaluation of peritoneal metastases |
| Q33438615 | A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovaria |
| Q89728607 | A global approach for the development of photodynamic therapy of peritoneal metastases regardless of their origin |
| Q35563228 | A historical perspective on colorectal liver metastases and peritoneal carcinomatosis: similar results, different treatments |
| Q90019372 | A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis |
| Q96171887 | A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneity |
| Q26800770 | A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature |
| Q47234459 | A new animal model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing mice in the treatment of peritoneal carcinomatosis of ovarian origin |
| Q40107374 | A new peritoneal carcinomatosis model in cyclosporine immunosuppressed rats. |
| Q68000085 | A new reproducible model of hepatic and peritoneal metastases from colonic carcinoma |
| Q24816094 | A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis |
| Q46868610 | A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin |
| Q40095907 | A novel suicide gene therapy targeting the overexpression of eukaryotic initiation factor 4E improves survival in a rat peritoneal carcinomatosis model |
| Q71446005 | A papillary cystadenocarcinoma of the ovary with peritoneal metastases diagnosed radiologically |
| Q44250551 | A patient with diffuse peritoneal metastases of GIST who was administered STI571 |
| Q36480757 | A patient with gastric cancer with peritoneal carcinomatosis treated with intraperitoneal chemotherapy who survived more than 5 years receiving repeated laparoscopic examinations: a case report |
| Q100515856 | A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers |
| Q33241119 | A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis |
| Q96962666 | A population-based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer |
| Q34580450 | A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial |
| Q87111970 | A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer |
| Q53117341 | A prospective study evaluating diffusion weighted magnetic resonance imaging (DW-MRI) in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies. |
| Q35987508 | A retrospective study on the sonographic findings of abdominal carcinomatosis in 14 cats |
| Q68970443 | A strategy for intestinal obstruction of peritoneal carcinomatosis |
| Q37478215 | A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin |
| Q35868066 | A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis |
| Q90468049 | A well differentiated neuroendocrine tumor of the jejunum with peritoneal carcinomatosis: A case report |
| Q34214323 | AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis model |
| Q64077678 | AB060. P-31. Complete response to immunotherapy in cholangiocarcinoma with peritoneal metastases and high PD-L1 expression: a case report |
| Q96820493 | ASO Author Reflection: Systemic Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy with Oxaliplatin in Patients with Colorectal Peritoneal Metastases |
| Q93020700 | ASO Author Reflections: Circulating Tumor DNA in Peritoneal Carcinomatosis |
| Q90813783 | ASO Author Reflections: Current Status of Treatment of Peritoneal Carcinomatosis from Gastric Cancer Origin in Spain: Is It Possible to Cure These Patients? |
| Q93169732 | ASO Author Reflections: How to Detect Peritoneal Metastases of Urachal Carcinoma? The Value of Diagnostic Laparoscopy and Abdominal Cytology in Staging This Rare Malignancy |
| Q57024205 | ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer |
| Q102204328 | ASO Author Reflections: Potential Therapeutic Implications and Prediction of Pathological Complete Response to Systemic Chemotherapy in Colorectal Peritoneal Metastases |
| Q100664514 | ASO Author Reflections: Prognostic Factors in Surgically Treated Peritoneal Metastases from Colorectal Cancer |
| Q92026473 | ASO Author Reflections: Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases |
| Q97078265 | ASO Author Reflections: Real-World Incidence of Peritoneal Carcinomatosis After Colon Cancer Resection and Why It Matters |
| Q90252408 | ASO Author Reflections: Tailoring the Extent of Peritoneal Resection for Peritoneal Metastases According to the Primary Tumor Site |
| Q95835798 | ASO Author Reflections: Targeting the Immunosuppressive Tumor Microenvironment for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer |
| Q92138023 | ASO Author Reflections: To Redo or Not to Redo, That is the Question: Assessing the Slings and Arrows of Repeat CRS/HIPEC in Patients with Recurrent or Progressive Peritoneal Carcinomatosis |
| Q57287355 | ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases |
| Q90977451 | ASO Author Reflections: Using the Gastric Cancer Peritoneal Carcinomatosis Risk Score to Inform Surveillance and Treatment |
| Q91019219 | ASO Author Reflections: What is the Best Therapeutic Strategy for Patients with Limited Synchronous Peritoneal Metastases of Colorectal Cancer? |
| Q42960903 | Abdominal Carcinomatosis associated with Vasomotor Disturbances. |
| Q42744755 | Abdominal Carcinomatosis, with probable Adrenal Involvement. |
| Q36200732 | Abdominal Sarcoidosis May Mimic Peritoneal Carcinomatosis |
| Q51682535 | Abdominal carcinomatosis attributed to metastatic breast carcinoma. |
| Q81889402 | Abdominal carcinomatosis in women with a history of breast cancer |
| Q74003700 | Abdominal carcinomatosis resulting in cancer cells in the routine vaginal slide; a case report |
| Q69848350 | Abdominal carcinomatosis secondary to ovarian carcinoma imaged by diphosphonate scanning |
| Q71796147 | Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery |
| Q70029449 | Abdominal splenosis mimicking abdominal carcinomatosis |
| Q84407589 | Abdominal tuberculosis leading to portal vein thrombosis, mimicking peritoneal carcinomatosis and liver cirrhosis |
| Q92883227 | Abdominal tuberculosis with a Pseudo-Sister Mary Joseph nodule mimicking peritoneal carcinomatosis |
| Q40432742 | Abdominal wall metastasis and peritoneal carcinomatosis after laparoscopic assisted colectomy for colon cancer |
| Q89698808 | Abdominopelvic Actinomycosis Mimicking Peritoneal Carcinomatosis: A Case Report |
| Q37345000 | Abdominopelvic actinomycosis mimicking disseminated peritoneal carcinomatosis |
| Q92011355 | Abnormal body fluid distribution due to peritoneal carcinomatosis: An overlooked cause of intradialytic hypotension |
| Q53264117 | Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi‐institutional study |
| Q52910910 | Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response. |
| Q35597857 | Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. |
| Q97554481 | Accuracy of peritoneal carcinomatosis extent diagnosis by initial FDG PET CT in epithelial ovarian cancer: A multicentre study of the FRANCOGYN research group |
| Q92187430 | Accuracy of radiologic- laparoscopic peritoneal carcinomatosis categorization in the prediction of surgical outcome |
| Q40144518 | Activatable fluorescent molecular imaging of peritoneal metastases following pretargeting with a biotinylated monoclonal antibody |
| Q34996489 | Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer |
| Q45939750 | Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial. |
| Q30429122 | Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial |
| Q90804466 | Acute malignant obstruction in patients with peritoneal carcinomatosis: The role of palliative surgery |
| Q96607434 | Adding diagnostic laparoscopy to computed tomography for the evaluation of peritoneal metastases in patients with colorectal cancer: A retrospective cohort study |
| Q83399253 | Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin |
| Q40519991 | Adenoviral-mediated gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice |
| Q39387407 | Adhesions due to peritoneal carcinomatosis caused by a renal carcinoma leading to mechanical gastric outlet obstruction: a case report |
| Q90097786 | Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for patients at High-Risk of Peritoneal Metastases |
| Q97547126 | Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases |
| Q34477640 | Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial |
| Q47795778 | Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review. |
| Q39017807 | Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review. |
| Q77961992 | Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats |
| Q55054425 | Administration of CDDP via the superior mesenteric artery for peritoneal carcinomatosis due to gastric cancer. |
| Q34009620 | Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. |
| Q91517938 | Aerosolization of Nanotherapeutics as a Newly Emerging Treatment Regimen for Peritoneal Carcinomatosis |
| Q34015030 | Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis |
| Q33909310 | Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms |
| Q80199761 | Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center |
| Q61809794 | Alteration of Adaptive Immunity in a Colorectal Peritoneal Carcinomatosis Model |
| Q92739335 | An 18-Year Experience in Diagnostic Laparoscopy of Peritoneal Carcinomatosis: Results from 744 Patients |
| Q42759089 | An elderly colon cancer patient with hepatic, lunge and peritoneal metastases was treated by hepatic arterial infusion and systemic chemotherapy-a case report |
| Q80203415 | An evolving role of perioperative intraperitoneal chemotherapy after cytoreductive surgery for colorectal peritoneal carcinomatosis |
| Q40257441 | An unusual case of a well-differentiated neuroendocrine tumour of the ileum with peritoneal carcinomatosis: a case report |
| Q34259388 | An unusual case of isolated peritoneal metastases from lung adenocarcinoma |
| Q50229322 | Analgesic Effectiveness of Systemic Lidocaine Administration for Abdominal Cancer Pain Caused by Peritoneal Carcinomatosis: A Case Series of 10 Patients |
| Q51031869 | Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. |
| Q70075213 | Animal experiments as a model for clinical trials of a new dosage form of mitomycin C for peritoneal carcinomatosis |
| Q93662415 | Antitumor effect in peritoneal carcinomatosis of intraperitoneal administration of a streptococcal preparation, OK-432: I. Experimental study in the rat |
| Q33384577 | Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecan |
| Q50092474 | Antitumor effectiveness and mechanism of action of Ru(II)/amino acid/diphosphine complexes in the peritoneal carcinomatosis progression. |
| Q46091817 | Appendiceal adenocarcinoids with peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy: a retrospective study of in vitro drug sensitivity and survival |
| Q80125743 | Appendiceal cancer and peritoneal carcinomatosis: a report of 29 cases |
| Q58602769 | Application of cryoablation to treat peritoneal carcinomatosis from gastric cancer in a rabbit model |
| Q86029894 | Ascites and malnutrition are predictive factors for incomplete cytoreductive surgery for peritoneal carcinomatosis from gastric cancer |
| Q68245805 | Ascitic fluid analysis in peritoneal carcinomatosis: comparison of various biochemical tests with ascitic cirrhotics |
| Q104568215 | Assessment of Tumor Response in Mice with Ovarian Peritoneal Carcinomatosis using Doppler Ultrasound of the Superior Mesenteric Artery and Celiac Trunk |
| Q38085569 | Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastases |
| Q41812830 | Assessment of clinical benefit and quality of life in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management of peritoneal carcinomatosis |
| Q53072691 | Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT. |
| Q64890714 | Association Between Secondary Peritoneal Hydatidosis and Peritoneal Carcinomatosis from Ovarian Cancer - A Case Report. |
| Q36372002 | Asymptomatic peritoneal carcinomatosis originating from benign cystic peritoneal mesothelioma |
| Q87075004 | Autofluorescent imaging in patients with peritoneal carcinomatosis |
| Q38207666 | Axillary lymph node metastasis as first presentation of peritoneal carcinomatosis from serous papillary ovarian cancer: case report and review of the literature |
| Q91071997 | Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer |
| Q86949298 | Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin |
| Q40112672 | Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study. |
| Q72908303 | Biliary cystadenocarcinoma with peritoneal carcinomatosis |
| Q35556903 | Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice |
| Q47245148 | Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin. |
| Q40154800 | Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration |
| Q35042000 | Biological intensity-modulated radiotherapy plus neoadjuvant chemotherapy for multiple peritoneal metastases of ovarian cancer: A case report |
| Q39821657 | Bioluminescence as gold standard for validation of optical imaging modalities in peritoneal carcinomatosis animal models |
| Q30241402 | Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review |
| Q37280394 | Bowel strangulation caused by massive intraperitoneal adhesion due to effective chemotherapy for multiple peritoneal metastases originating from descending colon cancer |
| Q33572980 | Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer |
| Q26776201 | Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes |
| Q34841141 | Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies. |
| Q83812032 | C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin |
| Q49381685 | CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort st |
| Q101121468 | CA125, CEA, CA19-9, and Heteroploid Cells in Ascites Fluid May Help Diagnose Peritoneal Carcinomatosis in Patients with Gastrointestinal and Ovarian Malignancies |
| Q48369162 | CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study |
| Q53079456 | CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer. |
| Q40537876 | CT Differentiation of Female Peritoneal Tuberculosis and Peritoneal Carcinomatosis From Normal-Sized Ovarian Cancer |
| Q68748220 | CT demonstration of peritoneal metastases after intraperitoneal injection of contrast media |
| Q73409459 | CT features of metastatic linitis plastica to the rectum in patients with peritoneal carcinomatosis |
| Q38196109 | CT imaging of peritoneal carcinomatosis and its mimics |
| Q68092641 | CT manifestations of peritoneal carcinomatosis |
| Q71208125 | CT of leiomyomatosis peritonealis disseminata mimicking peritoneal carcinomatosis |
| Q83920757 | CT versus intraoperative peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: importance of the difference between statistical significance and clinical relevance |
| Q53171509 | CT-Enteroclysis in the preoperative assessment of the small-bowel involvement in patients with peritoneal carcinomatosis, candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. |
| Q34325001 | CTHRC1 is associated with peritoneal carcinomatosis in colorectal cancer: a new predictor for prognosis |
| Q67791140 | Calcification of peritoneal carcinomatosis from gastric carcinoma: a CT demonstration |
| Q69492487 | Calcified peritoneal metastases from papillary cystadenocarcinoma of the ovary: CT features |
| Q45009335 | Camptothecine encapsulated composite drug delivery system for colorectal peritoneal carcinomatosis therapy: biodegradable microsphere in thermosensitive hydrogel |
| Q92619608 | Can We Accurately Identify Peritoneal Metastases Based on Their Appearance? An Assessment of the Current Practice of Intraoperative Gastrointestinal Cancer Staging |
| Q90901794 | Can [18F]F-FDG PET/CT be used to assess the pre-operative extent of peritoneal carcinomatosis in patients with colorectal cancer? |
| Q39879825 | Can antibody galactosylation be used to improve radioimmunotherapy of induced peritoneal carcinomatosis of colonic origin in the rat? |
| Q104680229 | Canadian guidelines on the management of colorectal peritoneal metastases |
| Q40842674 | Cancer Stem Cell Markers Are Associated With Distant Hematogenous Liver Metastases But Not With Peritoneal Carcinomatosis in Colorectal Cancer |
| Q89833420 | Cancer immunotherapy with STING agonist and PD-1 immune checkpoint inhibitor effectively suppresses peritoneal carcinomatosis of colon cancer |
| Q38971222 | Carbohydrate Antigen 19-9 Predicts Synchronous Peritoneal Carcinomatosis in Patients with Colorectal Cancer |
| Q79456651 | Carcinoma of stomach, with peritoneal metastases |
| Q89053388 | Cardiophrenic angle lymph node is an indicator of metastatic spread but not specifically peritoneal carcinomatosis in colorectal cancer patients: Results of a prospective validation study in 91 patients |
| Q104690745 | Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient |
| Q70787287 | Case study: abdominal carcinomatosis |
| Q43877228 | Castrate-resistant prostate cancer with peritoneal metastases treated with docetaxel-based chemotherapy |
| Q39456682 | Cathepsin B cleavable novel prodrug Ac-Phe-Lys-PABC-ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis: an experimental study |
| Q53042796 | Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: Results of a population-based study. |
| Q85059510 | Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis |
| Q92462064 | Chasing Rainbows? the Possibility of "Cure" in Patients with Colorectal Peritoneal Metastases Undergoing Cytoreductive Surgery and HIPEC-a Retrospective Study by INDEPSO |
| Q86889201 | Chemotherapy as palliative treatment for peritoneal carcinomatosis of gastric origin |
| Q40993801 | Chemotherapy treatment of chyloperitoneum and peritoneal carcinomatosis due to cervical cancer--review of literature |
| Q53314576 | Chronic peritoneal inflammation and nodules masquerading as peritoneal carcinomatosis in Birt-Hogg-Dube syndrome. |
| Q88091382 | Chronically Infected Urachal Remnant Mimicking Tumor With Peritoneal Carcinomatosis |
| Q96227047 | Circulating Tumor DNA as a Preoperative Marker of Recurrence in Patients with Peritoneal Metastases of Colorectal Cancer: A Clinical Feasibility Study |
| Q73131432 | Cisplatin combined with prostaglandin E1 chemotherapy in rat peritoneal carcinomatosis |
| Q93065734 | Clinical Efficacy of Combination Intravenous and Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis |
| Q40853593 | Clinical Outcomes of Patients with Extensive Peritoneal Carcinomatosis Following Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy |
| Q49039015 | Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin |
| Q102202281 | Clinical and Radiologic Predictors of a Pathologic Complete Response to Neoadjuvant Chemotherapy (NACT) in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases: Results of a Prospective Multi-center Study |
| Q86888405 | Clinical application of total parenteral nutrition in patients with peritoneal carcinomatosis |
| Q37363765 | Clinical course for patients with peritoneal carcinomatosis excluded from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q84135922 | Clinical effects of chemoimmunotherapy for patients with peritoneal carcinomatosis |
| Q85096405 | Clinical efficacy of cytoreductive surgery and hyperthermic chemotherapy in peritoneal carcinomatosis from gastric cancer |
| Q42378476 | Clinical efficacy of endostar combined with chemotherapy in the treatment of peritoneal carcinomatosis in gastric cancer: results from a retrospective study |
| Q90014867 | Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis |
| Q48045638 | Clinical history of patients with peritoneal carcinomatosis exluded from cytoreductive surgery & HIPEC. |
| Q87423137 | Clinical outcome of up-front surgery in patients with asymptomatic, incurable synchronous peritoneal carcinomatosis |
| Q98393075 | Clinical outcomes of curative treatment for colorectal liver metastases combined with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases: a systematic review and meta-analysis of current evidence |
| Q41625764 | Clinical pathway for peritoneal carcinomatosis from colon and rectal cancer: guidelines for current practice |
| Q50632276 | Clinical significance of minimal ascites of indeterminate nature in gastric adenocarcinoma without peritoneal carcinomatosis: long-term follow-up study. |
| Q50992676 | Clinical use of PET/CT in peritoneal carcinomatosis from colorectal cancer. |
| Q92584635 | Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma |
| Q73620601 | Clinics in diagnostic imaging (22). Calcified peritoneal carcinomatosis |
| Q92882182 | Colic and rectal tumors with peritoneal metastases treated with cytoreductive surgery and HIPEC: One homogeneous condition or two different diseases? A systematic review and meta-analysis |
| Q88005113 | Colorectal Cancer Peritoneal Metastases: Second-look Laparotomy, Prophylactic HIPEC, or Both? |
| Q85603547 | Colorectal Cancer With Peritoneal Metastases: A Plea for Cooperation Between Medical and Surgical Oncologists |
| Q91131634 | Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS) |
| Q64092130 | Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research |
| Q41612691 | Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives. |
| Q91732978 | Colorectal cancer peritoneal metastases: Biology, treatment and next steps |
| Q53435982 | Colorectal cancer with peritoneal metastases: Progress, not perfection. |
| Q87439621 | Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center |
| Q57167359 | Colorectal peritoneal carcinomatosis: What is the future of HIPEC? |
| Q92323504 | Colorectal peritoneal metastases: Optimal management review |
| Q90027688 | Colorectal peritoneal metastases: pathogenesis, diagnosis and treatment options - an evidence-based update |
| Q90112516 | Colorectal peritoneal metastases: still a nihilistic outlook? |
| Q87135298 | Colorectal resection with pelvic peritoneal carcinomatosis en-bloc resection in a male patient (with video) |
| Q57779503 | Combination Therapy Using Gemcitabine and Radioimmunotherapy in Nude Mice with Small Peritoneal Metastases of Colonic Origin |
| Q46469567 | Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin |
| Q57214522 | Combined Cytoreductive Surgery and Early Postoperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Gastric Cancer |
| Q35361079 | Combined suicide and cytokine gene therapy for peritoneal carcinomatosis |
| Q40606264 | Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes |
| Q96351880 | Combo-targeted nanoassemblies as a chemotherapy delivery system against peritoneal carcinomatosis colorectal cancer |
| Q50172326 | Comment On: Survival and Quality of Life Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colonic Origin |
| Q92650379 | Comment on "Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery" |
| Q89775802 | Comment: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer |
| Q83640620 | Comparative analysis of perioperative intraperitoneal chemotherapy regimen in appendiceal and colorectal peritoneal carcinomatosis |
| Q89171762 | Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma |
| Q53646381 | Comparison between MRI and CT in prediction of peritoneal carcinomatosis index (PCI) in patients undergoing cytoreductive surgery in relation to the experience of the radiologist. |
| Q34903258 | Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb |
| Q83495199 | Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy |
| Q35609723 | Comparison of PET with PET/CT in detecting peritoneal carcinomatosis: a meta-analysis |
| Q60956934 | Comparison of Survival in Patients with Isolated Peritoneal Carcinomatosis from Colorectal Cancer Treated with Cytoreduction and Melphalan or Mitomycin-C as Hyperthermic Intraperitoneal Chemotherapy Agent |
| Q34510371 | Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosis |
| Q37132189 | Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice |
| Q82699857 | Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer |
| Q84511644 | Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer |
| Q42615377 | Comparison of prognostic scores for patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q96646529 | Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer |
| Q97427225 | Comparison of the outcomes of cytoreductive surgery versus surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: a propensity score matching analysis |
| Q82436912 | Comparison of transcolonic NOTES and laparoscopic peritoneoscopy for the detection of peritoneal metastases |
| Q79345552 | Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis |
| Q84489060 | Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology |
| Q48645092 | Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI). |
| Q92504802 | Complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases: results of a propensity score matching analysis from France |
| Q43932503 | Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. |
| Q89833659 | Complete peritonectomy versus selective peritonectomy in peritoneal carcinomatosis secondary to colorectal cancer: a prospective comparative analysis of outcomes |
| Q43152083 | Complete resection after imatinib treatment of a gastrointestinal stromal tumor of the ileum with peritoneal metastases: report of a case |
| Q57571560 | Complete response of an HIV negative gastric Kaposi's sarcoma (KS) patient with peritoneal carcinomatosis by liposomal daunorubicin treatment |
| Q39918797 | Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: Risk factors for ICU admission and morbidity prognostic score. |
| Q52164104 | Complications and tolerance of heated intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis: results of a phase I-II study of peritoneal carcinomatosis from different sources |
| Q36758917 | Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases |
| Q90289571 | Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma |
| Q44470481 | Computed tomographic features of peritoneal carcinomatosis treated by intraperitoneal chemohyperthermia. |
| Q60920090 | Computed tomography imaging of ovarian peritoneal carcinomatosis: a pictorial review |
| Q44081666 | Concentration of FT and CDHP and 5-FU in the ascites fluid of patient with peritoneal carcinomatosis after new anti-cancer drug TS-1 oral administration |
| Q48645056 | Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay. |
| Q91823528 | Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial |
| Q39545121 | Connective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancer |
| Q43561598 | Constant intra-aortic infusion chemotherapy for advanced abdominal cancer--a technic and the effect in patients with peritoneal metastases |
| Q73140136 | Continuous hyperthermic peritoneal perfusion for peritoneal carcinomatosis |
| Q46637842 | Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study |
| Q41422131 | Conversion therapy for pancreatic cancer with peritoneal metastases using intravenous and intraperitoneal paclitaxel with S-1. |
| Q74390344 | Core biopsy in men with peritoneal carcinomatosis |
| Q91978352 | Correction to: Laparoscopic Hyperthermic Intraperitoneal Chemotherapy for Patients with Gastric Peritoneal Metastases: Limitations and Perspectives |
| Q91083801 | Correction to: Peritoneal Metastases in Colorectal Cancer |
| Q100405737 | Correction to: Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal Origin |
| Q92718462 | Correction to: Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience |
| Q103828238 | Correction to: The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of neoadjuvant chemotherapy |
| Q41889747 | Correction: Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin |
| Q53432098 | Correlation of Radiologic with Surgical Peritoneal Cancer Index Scores in Patients with Pseudomyxoma Peritonei and Peritoneal Carcinomatosis: How Well Can We Predict Resectability? |
| Q37489783 | Correlation of preoperative magnetic resonance imaging of peritoneal carcinomatosis and clinical outcome after peritonectomy and HIPEC after 3 years of follow-up: preliminary results |
| Q89285295 | Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Management of Colorectal Peritoneal Carcinomatosis |
| Q91252990 | Cost-Effectiveness Analysis of Cytoreductive Surgery and HIPEC Compared With Systemic Chemotherapy in Isolated Peritoneal Carcinomatosis From Metastatic Colorectal Cancer |
| Q81303388 | Cost-effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancer |
| Q82443706 | Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer |
| Q54998096 | Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer? |
| Q37566389 | Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma |
| Q53154650 | Crohn's disease-associated large and small bowel adenocarcinoma with peritoneal carcinomatosis: two case reports. |
| Q51737625 | Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids. |
| Q54064747 | Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer. |
| Q37770303 | Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends. |
| Q40698258 | Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. |
| Q49774282 | Curative versus palliative treatments for colorectal cancer with peritoneal carcinomatosis: a systematic review and meta-analysis |
| Q57171465 | Current Management and Future Opportunities for Peritoneal Metastases |
| Q50103945 | Current Management and Future Opportunities for Peritoneal Metastases: Peritoneal Mesothelioma |
| Q47569322 | Current Management of Peritoneal Carcinomatosis From Colorectal Cancer: The Role of Cytoreductive Surgery and Hyperthermic Peritoneal Chemoperfusion |
| Q89091663 | Current Opinion and Knowledge on Peritoneal Carcinomatosis: A Survey among a Swiss Oncology Network |
| Q100729199 | Current Opinion on Peritoneal Carcinomatosis Treatment: a Survey of the Indian Society of Peritoneal Surface Malignancies (ISPSM) |
| Q38098860 | Current management of peritoneal carcinomatosis from colorectal cancer |
| Q42863985 | Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer |
| Q37094755 | Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis |
| Q83047469 | Current status of colorectal cancer with peritoneal carcinomatosis |
| Q37991427 | Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer |
| Q34207816 | Current treatment options for colon cancer peritoneal carcinomatosis |
| Q39894798 | Cylindroma of the uuterine cervix with peritoneal metastases: report of a case and review of the literature |
| Q73126650 | Cystadenocarcinoma of ovary; twenty years survival after known peritoneal metastases; a case report |
| Q35644018 | Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec |
| Q71874435 | Cytologic assessment before and after intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis |
| Q80115072 | Cytoreduction and HIPEC for peritoneal carcinomatosis from colorectal origin: the Amsterdam experience |
| Q95532658 | Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer |
| Q35817844 | Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis |
| Q37413266 | Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei |
| Q87527317 | Cytoreduction and hyperthermic intraperitoneal chemotherapy: a feasible and effective option for colorectal cancer patients after emergency surgery in the presence of peritoneal carcinomatosis |
| Q36882819 | Cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis of ovarian cancer. |
| Q50179578 | Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma |
| Q64116538 | Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study |
| Q96608892 | Cytoreduction surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma |
| Q62711405 | Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Intraoperative Chemotherapy for Peritoneal Carcinomatosis Arising From Colon Adenocarcinoma |
| Q47240983 | Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer. |
| Q52683901 | Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience. |
| Q91988857 | Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis |
| Q93119128 | Cytoreductive Surgery and HIPEC for Recurrent Fibrolamellar Hepatocellular Carcinoma with Peritoneal Carcinomatosis |
| Q92210316 | Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP) |
| Q50093908 | Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Trial Results of a Phase 2, Randomized, Clinical Trial |
| Q90135126 | Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis |
| Q88283150 | Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis in the Elderly: A Case-Controlled, Multicenter Study |
| Q91799478 | Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis: Our Initial Experience |
| Q58409695 | Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis |
| Q55406271 | Cytoreductive Surgery and Normothermic Intraperitoneal Chemotherapy for Signet Ring Cell Appendiceal Adenocarcinoma With Peritoneal Metastases in the Setting of Cirrhosis. |
| Q36758936 | Cytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal Cancer |
| Q79398269 | Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience |
| Q94669805 | Cytoreductive surgery (CRS) with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) versus standard of care (SoC) in people with peritoneal metastases from colorectal, ovarian or gastric origin: protocol for a systematic review and individu |
| Q36160064 | Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details |
| Q42655076 | Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. |
| Q33562825 | Cytoreductive surgery and HIPEC for peritoneal carcinomatosis in the elderly |
| Q38067847 | Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies |
| Q50042838 | Cytoreductive surgery and HIPEC in the treatment of peritoneal metastases of sarcomas and other rare malignancies |
| Q53577988 | Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists. |
| Q40783676 | Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study |
| Q44664567 | Cytoreductive surgery and Hyperthermic intra-operative peritoneal chemotherapy with Cisplatin for gastric peritoneal Carcinomatosis Monocentric phase-2 nonrandomized prospective clinical trial |
| Q37087589 | Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerations |
| Q43408608 | Cytoreductive surgery and heated intra-peritoneal chemotherapy in the treatment of peritoneal carcinomatosis of colorectal origin: the need for practice altering data |
| Q91555624 | Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis from rare etiologies |
| Q34993227 | Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix |
| Q87916326 | Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy treatment of colorectal peritoneal metastases: cohort analysis of high volume disease and cure rate |
| Q96813784 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review |
| Q24236263 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis in patients with colorectal cancer |
| Q47110666 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center |
| Q80115088 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: higher complication rate for oxaliplatin compared to Mitomycin C |
| Q49945539 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: from novelty to routine in selected cases |
| Q53088982 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for managing peritoneal carcinomatosis from endometrial carcinoma: a single-center experience of 6 cases. |
| Q82664343 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival |
| Q37438233 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma |
| Q86991425 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in a liver graft recipient: a case report |
| Q87374662 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution |
| Q50558486 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience. |
| Q89941871 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases of colorectal origin |
| Q34928467 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial |
| Q90346763 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal carcinomatosis from a pancreatic cystadenocarcinoma: A case report |
| Q55258604 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience. |
| Q24800974 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer |
| Q44623386 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer with peritoneal metastases: a single centre experience |
| Q38878140 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care |
| Q48570130 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: initial experience in Oaxaca, Mexico. |
| Q99563897 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with or without early post-operative intraperitoneal chemotherapy for appendix neoplasms with peritoneal metastases: A propensity score analysis |
| Q36350667 | Cytoreductive surgery and intraoperative intraperitoneal hyperthermic chemotherapy in patients with peritoneal carcinomatosis of colorectal origin |
| Q75244449 | Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer |
| Q50169032 | Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer |
| Q42642753 | Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study |
| Q34326741 | Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases |
| Q37339466 | Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer: 2-year follow-up results at a single institution in Korea |
| Q38112342 | Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin |
| Q87048847 | Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial |
| Q36284824 | Cytoreductive surgery and intraperitoneal chemotherapy. Treatment for peritoneal carcinomatosis |
| Q36199837 | Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma |
| Q84080127 | Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis |
| Q35648472 | Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma |
| Q95811506 | Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? |
| Q80055967 | Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival |
| Q37526718 | Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma |
| Q36002125 | Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly |
| Q43037375 | Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years' experience of a new centre for peritoneal surface malignancies |
| Q61630713 | Cytoreductive surgery associated to hyperthermic intraperitoneal chemoperfusion for desmoplastic round small cell tumor with peritoneal carcinomatosis in young patients |
| Q90823032 | Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis |
| Q53286355 | Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. |
| Q34354500 | Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone |
| Q35234968 | Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy only |
| Q34258723 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for patients with peritoneal carcinomatosis from colorectal cancer: a phase II study from a Chinese center |
| Q41547533 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence |
| Q46238919 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases |
| Q34992944 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study |
| Q34819493 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from colorectal cancer: a case-control study from a Chinese center |
| Q99724037 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: The prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios |
| Q48831086 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center |
| Q37260591 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies |
| Q40754147 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center |
| Q85707999 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from colorectal cancer |
| Q41902566 | Cytoreductive surgery plus hyperthermic perioperative chemotherapy for selected patients with peritoneal metastases from colorectal cancer: a new standard of care or an experimental approach? |
| Q84672419 | Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? |
| Q34446650 | Cytoreductive surgery under aminolevulinic acid-mediated photodynamic diagnosis plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from ovarian cancer and primary peritoneal carcinoma: results of a phase I tria |
| Q39801266 | Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin |
| Q41822274 | Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colorectal cancer with peritoneal carcinomatosis: Clinical outcomes at 2 tertiary referral centers in Korea |
| Q92027318 | Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for endometrial cancer-derived peritoneal metastases: a systematic review |
| Q44055949 | Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis secondary to urachal adenocarcinoma |
| Q37512888 | Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancer |
| Q50803290 | Cytotoxic effects of acoustic cavitation on HT-29 cells and a rat peritoneal carcinomatosis in vitro. |
| Q42364442 | DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy |
| Q36314223 | Dealing with microscopic peritoneal metastases of epithelial ovarian cancer. A surgical challenge. |
| Q38054557 | Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review |
| Q91733002 | Delta peritoneal cancer index (ΔPCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastases |
| Q36691447 | Depth of colorectal-wall invasion and lymph-node involvement as major outcome factors influencing surgical strategy in patients with advanced and recurrent ovarian cancer with diffuse peritoneal metastases |
| Q51917328 | Design of a bio-mathematical prediction model using serum tumor markers and immunohistochemistry in peritoneal carcinomatosis with ovarian involvement: a pilot study. |
| Q91600308 | Detection of Unusual Peritoneal Metastases of Prostate Cancer With 68Ga-Prostate-Specific Membrane Antigen PET/CT |
| Q38019109 | Detection of gastric cancer peritoneal metastases by peritoneal lavage: Current limitations and future perspectives |
| Q46772636 | Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT. |
| Q41465869 | Detection of peritoneal carcinomatosis by EUS fine-needle aspiration: impact on staging and resectability (with videos). |
| Q30410655 | Detection of peritoneal metastases |
| Q97643016 | Development and Validation of an Image-based Deep Learning Algorithm for Detection of Synchronous Peritoneal Carcinomatosis in Colorectal Cancer |
| Q47823943 | Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review. |
| Q89999982 | Development of a near infrared protein nanoprobe targeting Thomsen-Friedenreich antigen for intraoperative detection of submillimeter nodules in an ovarian peritoneal carcinomatosis mouse model |
| Q40991384 | Development of systemic immunologic responses against hepatic metastases during gene therapy for peritoneal carcinomatosis with retroviral HS-tk and ganciclovir |
| Q37132088 | Diagnosis and management of peritoneal carcinomatosis arising from adenocarcinoma of the colon and rectum |
| Q36128985 | Diagnosis and management of peritoneal metastases from ovarian cancer |
| Q34666643 | Diagnosis of Peritoneal Metastases with Abdominal Malignancies: Role of ADC Measurement on Diffusion Weighted MRI. |
| Q80842963 | Diagnosis of peritoneal carcinomatosis by EUS-guided FNA |
| Q81363005 | Diagnosis of peritoneal carcinomatosis: transgastric versus transrectal EUS-guided FNA or percutaneous paracentesis |
| Q89689894 | Diagnostic Laparoscopy and Abdominal Cytology Reliably Detect Peritoneal Metastases in Patients with Urachal Adenocarcinoma |
| Q90894017 | Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery |
| Q89253840 | Diagnostic Value of Carcinoembryonic Antigen in Ascites for Colorectal Cancer with Peritoneal Carcinomatosis |
| Q52933828 | Diagnostic accuracy of 18F-FDG PET/CT for detection of peritoneal carcinomatosis; a systematic review and meta-analysis. |
| Q52956821 | Diagnostic accuracy of MDCT in the evaluation of patients with peritoneal carcinomatosis from ovarian cancer: is delayed enhanced phase really effective? |
| Q59291346 | Diagnostic accuracy of hand-assisted laparoscopy in predicting resectability of peritoneal carcinomatosis from gynecological malignancies |
| Q89816481 | Diagnostic performance of CT for differentiating peritoneal tuberculosis from peritoneal carcinomatosis: a systematic review and meta-analysis |
| Q36137782 | Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis. |
| Q89741741 | Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis |
| Q55385444 | Diagnostic value of whole-body MRI with diffusion-weighted sequence for detection of peritoneal metastases in colorectal malignancy. |
| Q87464659 | Did Peritoneal Metastases From Colorectal Cancers Experience Similar Survival With Resected Liver Metastases? |
| Q38259443 | Differences in CT features of peritoneal carcinomatosis, sarcomatosis, and lymphomatosis: retrospective analysis of 122 cases at a tertiary cancer institution |
| Q93186380 | Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal Carcinomatosis |
| Q53046246 | Differential diagnosis between splenic nodules and peritoneal metastases with contrast-enhanced ultrasound based on signal-intensity characteristics during the late phase. |
| Q92715087 | Differentiation of peritoneal tuberculosis from peritoneal carcinomatosis by the Omental Rim sign. A new sign on contrast enhanced multidetector computed tomography |
| Q100655390 | Diffuse Ectopic Deciduosis Imitating Peritoneal Carcinomatosis with Acute Abdomen Presentation: A Case Report and Literature Review |
| Q57640668 | Diffuse Peritoneal and Bowel Wall Infiltration by Light Chain-AL Amyloidosis with Omental Calcification Mimicking Abdominal Carcinomatosis - An Elderly Female with Incidental Finding of Light Chain Monoclonal Gammopathy of Undetermined Significance ( |
| Q42269677 | Diffuse abdominal splenosis mimicking peritoneal metastases in a 35-year-old man with a resectable carcinoma of the ampulla of vater |
| Q71636552 | Diffuse and gross peritoneal carcinomatosis treated by intraperitoneal hyperthermic chemoperfusion |
| Q41846243 | Diffuse gastric cancer with peritoneal carcinomatosis can mimic Crohn's disease |
| Q81167853 | Diffuse granulomatous mesenteric disease caused by intravesical bacillus Calmette-Guérin instillation masquerading as peritoneal carcinomatosis |
| Q53222929 | Diffuse intraabdominal fibrosis and inflammation mimicking peritoneal carcinomatosis recurred after surgery for borderline ovarian tumor misdiagnosed by 18F-fluorodeoxyglucose-positron emission tomography. |
| Q74249179 | Diffuse mesenteric and omental infiltration by amyloidosis with omental calcification mimicking abdominal carcinomatosis |
| Q99638022 | Diffuse peritoneal carcinomatosis with ascites and disseminated bone marrow carcinomatosis as initial presentation of occult breast cancer |
| Q37848932 | Diffuse peritoneal chlamydial infection presenting as possible ovarian peritoneal carcinomatosis in an adolescent female |
| Q82651657 | Diffuse peritoneal lymphomatosis simulating peritoneal carcinomatosis |
| Q50772344 | Diffuse peritoneal metastases from primary colon cancer demonstrated by Tc-99m-labeled red blood cell scintigraphy. |
| Q83519421 | Diffusion-weighted magnetic resonance imaging detection of renal cancer presenting with diffuse peritoneal metastases in a patient with hemodialysis-associated acquired cystic disease of the kidney |
| Q91092315 | Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: Diagnostic performance in correlation with surgical findings |
| Q85326953 | Digestive fistulas after cytoreductive surgery & HIPEC in peritoneal carcinomatosis |
| Q33782195 | Disseminated Coccidioidomycosis Presenting as Carcinomatosis Peritonei and Intestinal Coccidioidomycosis in a Patient with HIV. |
| Q104584062 | Distinguishing peritoneal tuberculosis from peritoneal carcinomatosis: a challenge |
| Q98653896 | Distribution Characteristics of Colorectal Peritoneal Carcinomatosis Based on the Positron Emission Tomography/Peritoneal Cancer Index |
| Q50034110 | Does upfront therapy with cytoreductive surgery and HIPEC confer a survival benefit in patients with synchronous gastric peritoneal carcinomatosis when compared with patients with metachronous gastric peritoneal carcinomatosis? |
| Q72115892 | Don't forget prostatic carcinoma in abdominal carcinomatosis |
| Q39891547 | Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer |
| Q38183786 | Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer |
| Q46634264 | Dual anti-cancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis: a feasibility and pharmacokinetic study. |
| Q52988475 | EDUCATION AND IMAGING. Gastrointestinal: Positron emission tomography/computed tomography imaging of peritoneal carcinomatosis secondary to prostate adenocarcinoma. |
| Q37737927 | ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors |
| Q97587838 | EPAS1 promotes peritoneal carcinomatosis of non-small-cell lung cancer by enhancing mesothelial-mesenchymal transition |
| Q92531637 | ERRATUM Improving Anti-Tumor Activity of Curcumin by Polymeric Micelles in Thermosensitive Hydrogel System in Colorectal Peritoneal Carcinomatosis Model (Journal of Biomedical Nanotechnology, Vol. 11(7), pp. 1173-1182 (2015)) |
| Q83027680 | EUS-guided FNA of peritoneal carcinomatosis |
| Q84311446 | EUS-guided FNA of peritoneal carcinomatosis in patients with unknown primary malignancy |
| Q41203836 | Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study |
| Q68353048 | Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies |
| Q94946085 | Echinococcosis with the image of peritoneal carcinomatosis |
| Q68560315 | Echographic diagnosis of peritoneal metastases in patients with ascites |
| Q40678551 | Effect of antiadhesive agents on peritoneal carcinomatosis in an experimental model. |
| Q47584170 | Effect of yttrium-90-labeled anti-carcinoembryonic antigen monoclonal antibody on the morphology and phenotype of human tumors grown as peritoneal carcinomatosis in athymic mice |
| Q88091218 | Effects of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Neoadjuvant Intraperitoneal/Systemic Chemotherapy on Peritoneal Metastases from Gastric Cancer |
| Q81756386 | Effects of natural polysaccharides on the growth and peritoneal carcinomatosis of human gastric adenocarcinoma in a nude mouse model |
| Q102333486 | Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report |
| Q89734122 | Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites |
| Q96110910 | Efficacy of intraperitoneally administered paclitaxel for colorectal cancer with peritoneal metastases |
| Q90917507 | Efficacy of postoperative intraperitoneal hyperthermic perfusion chemotherapy with oxaliplatin + 5-Fluorouracil in the treatment of gastric cancer patients with peritoneal carcinomatosis |
| Q39358580 | Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites |
| Q33912543 | Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis |
| Q68134702 | Endometrioid carcinoma of the ovary presenting with an enlarged inguinal lymph node without evidence of abdominal carcinomatosis |
| Q100486138 | Endoscopic Ultrasound-Guided Random Omental Fine Needle Aspiration: A Novel Technique for the Diagnosis of Peritoneal Carcinomatosis |
| Q36354776 | Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer. |
| Q39300912 | Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest |
| Q44639174 | Enhancing the objectivity of the Japanese classification of peritoneal metastases from colorectal cancer. |
| Q41595425 | Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study |
| Q33398652 | Epidural analgesia for surgical treatment of peritoneal carcinomatosis: a risky technique? |
| Q34064102 | Epithelial-mesenchymal transition and somatic alteration in colorectal cancer with and without peritoneal carcinomatosis |
| Q87876237 | Erratum to: A feasibility study of the use of computed virtual chromoendoscopy for laparoscopic evaluation of peritoneal metastases |
| Q86961780 | Erratum to: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer |
| Q84233810 | Establishing evidence for change in ovarian cancer surgery--proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis |
| Q33548523 | Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer |
| Q95527482 | Establishment of a novel model of peritoneal carcinomatosis of the peritoneal extension type |
| Q68006239 | Etoposide microcrystals suspended in oil: a new dosage form to peritoneal carcinomatosis in mice |
| Q38766382 | Evaluation of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin in the Era of Value-Based Medicine |
| Q91827154 | Evaluation of Enhanced Recovery After Following a Surgical Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis |
| Q90195878 | Evaluation of a new histological grading system for assessing the response to chemotherapy of peritoneal metastases from colorectal cancer: A mouse model study |
| Q79662626 | Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis |
| Q33777576 | Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin |
| Q72873199 | Evaluation of computed tomography in patients with peritoneal carcinomatosis |
| Q82810703 | Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis |
| Q83143755 | Evaluation of preoperative computed tomography in estimating peritoneal cancer index in peritoneal carcinomatosis |
| Q89814530 | Evaluation of repeat cytoreductive surgery and heated intraperitoneal chemotherapy for patients with recurrent peritoneal carcinomatosis from appendiceal and colorectal cancers: a multicentre Canadian study |
| Q87592336 | Evaluation of single-port laparoscopy for peritoneal carcinomatosis assessment in advanced ovarian cancer |
| Q48321705 | Evaluation of the peritoneal carcinomatosis index with CT and MRI. |
| Q95329203 | Evaluation of the relationship between lactacidemia and postoperative complications after cytoreduction surgery for peritoneal carcinomatosis |
| Q82299306 | Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using (18)F-FDG PET |
| Q37583768 | Evidence-based medicine in the treatment of peritoneal carcinomatosis: Past, present, and future |
| Q93146542 | Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience |
| Q91279427 | Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience: ERRATUM |
| Q87158778 | Evolution of Treatments for Peritoneal Metastases From Colorectal Cancer |
| Q85092366 | Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives? |
| Q37787404 | Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy |
| Q89540306 | Exosomal microRNA in peritoneal fluid as a biomarker of peritoneal metastases from gastric cancer |
| Q95647753 | Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models |
| Q41584129 | Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers |
| Q40793895 | Experimental assessment of tumor growth and dissemination of a microscopic peritoneal carcinomatosis after CO2 peritoneal insufflation or laparotomy |
| Q40424085 | Experimental radioimmunoguided surgery for peritoneal metastases of gastric cancer using anticarcinoembryonic antigen-specific T84.66 F(ab')2. |
| Q73807768 | Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin |
| Q50442997 | Experimental study of antiangiogenic and photodynamic therapies combination for treatment of peritoneal carcinomatosis: preliminary results |
| Q56906350 | Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis |
| Q48185591 | Expression of microRNAs in the ascites of patients with peritoneal carcinomatosis and peritonitis |
| Q43596237 | Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin |
| Q36820312 | Extensive peritoneal carcinomatosis secondary to renal cell carcinoma with sarcomatoid and rhabdoid differentiation |
| Q90838989 | Extent of Peritoneal Metastases on Preoperative DW-MRI is Predictive of Disease-Free and Overall Survival for CRS/HIPEC Candidates with Colorectal Cancer |
| Q92829437 | Extent of Peritoneal Resection for Peritoneal Metastases: Looking Beyond a Complete Cytoreduction |
| Q44408342 | Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. |
| Q47998828 | External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal Cancer |
| Q40296834 | External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer |
| Q33874280 | Extraovarian Primary Peritoneal Carcinomatosis: A Case Report |
| Q46308152 | FDG uptake in parahepatic brown fat mimics peritoneal carcinomatosis in a malignant ovarian germ cell tumor: resolution with temperature control. |
| Q79095898 | FDG-PET Patterns of Abdominal Carcinomatosis |
| Q90244152 | FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study |
| Q88422133 | FOREWORD - special issue of International Journal of Hyperthermia - cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases |
| Q101227765 | Factors Prognostic for Peritoneal Metastases from Colorectal Cancer Treated with Surgery |
| Q91063708 | Factors affecting R0 resection of colorectal cancer with synchronous peritoneal metastases: a multicenter prospective observational study by the Japanese Society for Cancer of the Colon and Rectum |
| Q37586264 | Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil |
| Q82918768 | Factors dictating outcomes in patients with colorectal cancer and peritoneal carcinomatosis: selection, resection, or convection? |
| Q78743915 | Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis |
| Q80337657 | Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer |
| Q70362620 | Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosis |
| Q37694182 | Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study. |
| Q87466537 | Feasibility of adjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in a short stay setting in patients with colorectal cancer at high risk of peritoneal carcinomatosis |
| Q98953652 | Feasibility of diaphragmatic interventions in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A 20-year experience |
| Q51151303 | Feasibility of intraperitoneal Trastuzumab treatment in a patient with peritoneal carcinomatosis from gastric cancer. |
| Q79317617 | Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis |
| Q90358595 | Feasibility study of intraperitoneal docetaxel combined with intravenous cisplatin and oral S-1 for gastric cancer patients with peritoneal carcinomatosis |
| Q52689377 | Features and Treatment of Peritoneal Metastases from Solid Pseudopapillary Neoplasms of the Pancreas. |
| Q53783738 | Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up. |
| Q73931202 | Flow cytometry in the diagnosis of peritoneal carcinomatosis |
| Q30488757 | Fluorescence Imaging After Indocyanine Green Injection for Detection of Peritoneal Metastases in Patients Undergoing Cytoreductive Surgery for Peritoneal Carcinomatosis From Colorectal Cancer: A Pilot Study |
| Q50002298 | Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations |
| Q90523384 | Fluorescent Nanoparticles for the Guided Surgery of Ovarian Peritoneal Carcinomatosis |
| Q53061504 | Focal fatty infiltration in Segment IV of the liver mimicking peritoneal carcinomatosis on CT and MR imaging. |
| Q46220720 | Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!). |
| Q47932497 | Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin |
| Q90856229 | Foreign body granuloma reaction following SIRT mimicking peritoneal metastases: a word of caution |
| Q50070298 | From utopia to reality: increased survival in peritoneal carcinomatosis treated with cytoreduction and hyperthermic intraperitoneal chemotherapy |
| Q94674187 | Functional tumour burden of peritoneal carcinomatosis derived from DWI could predict incomplete tumour debulking in advanced ovarian carcinoma |
| Q73342097 | Ga-67 citrate and Tc-99m MDP uptake in peritoneal metastases from a poorly differentiated adenocarcinoma of gynecologic origin |
| Q90762231 | Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases |
| Q51737300 | Gastric Cancer Cells in Peritoneal Lavage Fluid: A Systematic Review Comparing Cytological with Molecular Detection for Diagnosis of Peritoneal Metastases and Prediction of Peritoneal Recurrences. |
| Q92191312 | Gastric Cancer Peritoneal Carcinomatosis Risk Score |
| Q90726961 | Gastric Linitis Plastica and Peritoneal Carcinomatosis as First Manifestations of Occult Breast Carcinoma: A Case Report and Literature Review |
| Q34240700 | Gastric cancer cell supernatant causes apoptosis and fibrosis in the peritoneal tissues and results in an environment favorable to peritoneal metastases, in vitro and in vivo |
| Q95934581 | Gastric cancer with peritoneal metastases: Efficiency of standard treatment methods |
| Q37697571 | Gastric peritoneal carcinomatosis - a retrospective review |
| Q26801201 | Gastrointestinal Cancers With Peritoneal Carcinomatosis: Surgery and Hyperthermic Intraperitoneal Chemotherapy |
| Q35567689 | Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab |
| Q47198560 | Gene expression microarray-based assay to determine tumor site of origin in a series of metastatic tumors to the ovary and peritoneal carcinomatosis of suspected gynecologic origin |
| Q42593114 | Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes |
| Q35216296 | Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis |
| Q36946716 | Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites |
| Q54466584 | Genitourinary resection at the time of cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis is not associated with increased morbidity or worsened oncologic outcomes: a case-matched study. |
| Q33772579 | Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin. |
| Q67355905 | Giant teratomas with benign glial abdominal seeding, mimicking diffuse abdominal carcinomatosis |
| Q86504700 | Glisson capsulectomy for extensive superficial liver involvement in peritoneal carcinomatosis (with video) |
| Q90413942 | Gonadotropin-Releasing Hormone Receptor-Targeted Near-Infrared Fluorescence Probe for Specific Recognition and Localization of Peritoneal Metastases of Ovarian Cancer |
| Q85549838 | Granulomatous peritonitis after ruptured teratoma mimicking peritoneal carcinomatosis |
| Q90934531 | HIPEC IN THE MANAGEMENT OF PERITONEAL CARCINOMATOSIS AND POTENTIAL MARKERS OF TREATMENT EFFICIENCY |
| Q84265068 | HIPEC for peritoneal carcinomatosis: does an associated urologic procedure increase morbidity? |
| Q53757849 | HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin. |
| Q53385584 | Heated chemotherapy improves survival and quality of life in peritoneal carcinomatosis patients. |
| Q43910359 | Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution |
| Q45059053 | Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance |
| Q40569299 | Hemorrhagic peritoneal carcinomatosis treated with a weekly schedule of carboplatin and paclitaxel. A case report. |
| Q64934962 | Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases. |
| Q72808705 | Hepatic hydatidosis in West Africa. Association with peritoneal carcinomatosis |
| Q37801303 | Hepatocellular carcinoma peritoneal metastases: report of three cases and collective review of the literature |
| Q47196405 | Heterocellular 3D scaffolds as biomimetic to recapitulate the tumor microenvironment of peritoneal metastases in vitro and in vivo. |
| Q80489973 | Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis |
| Q81958376 | Hidden opportunities in cytoreductive surgery for peritoneal carcinomatosis of colorectal origin |
| Q79775363 | High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis |
| Q74474381 | High resistance index of Doppler ultrasound in tuberculous peritonitis presenting as abdominal carcinomatosis: report of two cases |
| Q104793336 | High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy |
| Q67275363 | Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix |
| Q33247614 | Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations |
| Q37793872 | Hormone refractory carcinoma prostate with peritoneal metastases and malignant ascites without skeletal involvement: A case report and review of literature |
| Q73535826 | Human serum albumin tagged with II31 in patients with ascites caused by abdominal carcinomatosis and portal cirrhosis; the rates of interchange between the vascular compartments and peritoneal cavity |
| Q39966576 | Hyperthermia and fibrinolytic therapy do not improve the beneficial effect of radioimmunotherapy following cytoreductive surgery in rats with peritoneal carcinomatosis of colorectal origin |
| Q39556650 | Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: an experimental study. |
| Q28077394 | Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal Carcinomatosis |
| Q98992405 | Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis |
| Q88142826 | Hyperthermic chemotherapy intra-abdominal laparoscopic approach: development of a laparoscopic model using CO2 recirculation system and clinical translation in peritoneal carcinomatosis |
| Q73095063 | Hyperthermic intra-peritoneal chemotherapy (HIPEC) in patients with peritoneal pseudomyxoma or peritoneal metastases of colorectal carcinoma; good preliminary results from the Netherlands Cancer Institute |
| Q73330121 | Hyperthermic intraoperative intraperitoneal chemotherapy for peritoneal carcinomatosis and sarcomatosis using a cardioplegia heat exchanger and a two-pump system: a case report |
| Q62711443 | Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis |
| Q53528667 | Hyperthermic intraperitoneal chemoperfusion is an option for treatment of peritoneal carcinomatosis in children. |
| Q44005555 | Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CS) as treatment of peritoneal carcinomatosis: preliminary results in Croatia |
| Q91145085 | Hyperthermic intraperitoneal chemotherapy (HIPEC). Mechanisms of action and the role of HIPEC in the treatment of peritoneal carcinomatosis |
| Q87502130 | Hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for the treatment of peritoneal carcinomatosis in pediatric solid malignancies: a single institution experience |
| Q36570910 | Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis of colorectal origin: a novel treatment strategy with promising results in selected patients |
| Q97095282 | Hyperthermic intraperitoneal chemotherapy combined with systemic chemotherapy for gastric cancer peritoneal carcinomatosis: A protocol for systematic review and meta-analysis of randomized controlled trials |
| Q99409867 | Hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: still a necessity? |
| Q54270096 | Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia. |
| Q36566249 | Hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis of digestive and peritoneal origin: rationale |
| Q92463681 | Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature |
| Q33418610 | Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis |
| Q46463103 | Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysis |
| Q91749747 | Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure |
| Q90293723 | Hyperthermic intraperitoneal chemotherapy with oxaliplatin-Still not the standard of care for patients with colorectal peritoneal metastases |
| Q40552455 | Hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from gastric adenocarcinoma |
| Q77108197 | Hypopharyngeal carcinoma with clinical peritoneal carcinomatosis: a report of two patients |
| Q39994801 | Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice |
| Q40345488 | ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention |
| Q79358903 | ICAM-1 mediated tumor-mesothelial cell adhesion is modulated by IL-6 and TNF-alpha: a potential mechanism by which surgical trauma increases peritoneal metastases |
| Q48272417 | ICG-fluorescence imaging for detection of peritoneal metastases and residual tumoral scars in locally advanced ovarian cancer: A pilot study |
| Q45985009 | Identification and quantification of peritoneal metastases in patients with ovarian cancer with multidetector computed tomography: correlation with surgery and surgical outcome. |
| Q94472352 | Identification of pharmacogenetic biomarkers for efficacy of cytoreductive surgery plus hyperthermic intraperitoneal mitomycin C in patients with colorectal peritoneal metastases |
| Q88676642 | IgG4-Related Disease Simulating Carcinoma Colon With Diffuse Peritoneal Carcinomatosis on 18F-FDG PET/CT |
| Q100763383 | IgG4-related disease mimicking renal pelvis tumor with peritoneal carcinomatosis |
| Q95369105 | Ileal perforation following cetuximab and FOLFIRI chemotherapy in a patient with ascending colon cancer with peritoneal carcinomatosis |
| Q42253485 | Image Findings of Rare Case of Peritoneal Carcinomatosis from Non Small Cell Lung Cancer and Response to Erlotinib in F-18 FDG Positron Emission Tomography/Computed Tomography |
| Q44217685 | Imaging diagnosis-hypoglycemia associated with cholangiocarcinoma and peritoneal carcinomatosis in a horse |
| Q89214365 | Imaging for Peritoneal Metastases |
| Q33840377 | Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review |
| Q37150817 | Imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls |
| Q53056447 | Imaging spectrum of peritoneal carcinomatosis on FDG PET/CT. |
| Q46489542 | Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis : a Hoosier Oncology Group trial. |
| Q98895126 | Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study |
| Q88011738 | Immuno-PCI: a proposal for the implementation of "seed and soil" concept in the treatment of peritoneal carcinomatosis from colorectal cancer |
| Q34867868 | Immunohistochemistry - microarray analysis of patients with peritoneal metastases of appendiceal or colorectal origin |
| Q67809753 | Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure |
| Q83492138 | Immunotherapy of peritoneal carcinomatosis with catumaxomab |
| Q40332575 | Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial |
| Q90270388 | Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review |
| Q37683464 | Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study |
| Q92404956 | Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study |
| Q44892132 | Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin |
| Q92200782 | Impact of anesthesia management during cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for the treatment of colorectal peritoneal carcinomatosis on intra- and postoperative outcomes: A systematic review protocol |
| Q97545282 | Impact of extent of disease on 1-year healthcare costs in patients who undergo cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: retrospective observational cohort study |
| Q87416761 | Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial |
| Q39922489 | Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades |
| Q91251528 | Impact of peritoneal carcinomatosis on clinical outcomes of patients receiving self-expandable metal stents for malignant colorectal obstruction |
| Q96607444 | Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG |
| Q37662262 | Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy |
| Q40548385 | Impacts of low peritoneal cancer index on the survival outcomes of patient with peritoneal carcinomatosis of colorectal origin |
| Q36114521 | Implantation Peritoneal Carcinomatosis of Ovarian Origin. |
| Q73090921 | Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery |
| Q42650727 | Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma |
| Q36694446 | Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study |
| Q49171796 | Improvement of anti-cancer drug efficacy via thermosensitive hydrogel in peritoneal carcinomatosis in gastric cancer. |
| Q38840763 | Improving Anti-Tumor Activity of Curcumin by Polymeric Micelles in Thermosensitive Hydrogel System in Colorectal Peritoneal Carcinomatosis Model |
| Q85679890 | Improving timely detection and recording of colorectal peritoneal metastases |
| Q90418977 | In response to: Establishing evidence for change in ovarian cancer surgery - Proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis |
| Q30486862 | In vivo effects of cavitation alone or in combination with chemotherapy in a peritoneal carcinomatosis in the rat. |
| Q84066384 | In-vivo effect of somatostatin analog, lanreotide, and/or grp antagonist, bim-26226, on the growth of colon-cancer peritoneal carcinomatosis in the rat |
| Q98514583 | Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands |
| Q92706945 | Incidence and risk factors for peritoneal carcinomatosis following open radical cystectomy |
| Q83353680 | Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer |
| Q46155637 | Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study |
| Q38160680 | Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin. |
| Q35110064 | Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients |
| Q80378429 | Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy |
| Q38514813 | Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: A multi-institutional analysis. |
| Q104063029 | Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study |
| Q39864102 | Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy |
| Q40442036 | Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer |
| Q71350014 | Increased uptake of I-123 IMP in peritoneal metastases of hepatocellular carcinoma |
| Q41964894 | Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer |
| Q97586643 | Indocyanine green fluorescence-guided intraoperative detection of peritoneal carcinomatosis: systematic review |
| Q72639856 | Induced pneumoperitoneum in CT evaluation of peritoneal carcinomatosis |
| Q42287221 | Induction of Proteases in Peritoneal Carcinomatosis, the Role of ICAM-1/CD43 Interaction. |
| Q88344975 | Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study |
| Q57491345 | Inflammatory bowel disease with peritoneal metastases: A complex and extremely variable disease |
| Q64974178 | Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study. |
| Q89471694 | Influence of peritoneal carcinomatosis on perioperative outcome in palliative gastric bypass for malignant gastric outlet obstruction - a retrospective cohort study |
| Q36538308 | Influence of surgical technique in the peritoneal carcinomatosis surgical wound implant: experimental model in mice |
| Q46585561 | Inguinal canal as an anatomic sanctuary site of relapse in peritoneal carcinomatosis previously treated with intraperitoneal chemotherapy |
| Q79809346 | Intense FDG activity in peritoneal tuberculosis mimics peritoneal carcinomatosis |
| Q39453397 | Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer |
| Q92015240 | Interleukin‑33 expression in ovarian cancer and its possible suppression of peritoneal carcinomatosis |
| Q55152522 | Intra-abdominal chemotherapy for peritoneal metastases comes of age? |
| Q37101337 | Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer |
| Q39661421 | Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model. |
| Q37585146 | Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results |
| Q44554117 | Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin. |
| Q41134426 | Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and sarcomatosis |
| Q84390840 | Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control study |
| Q91295339 | Intraoperative macroscopic tumour consistency is associated with overall survival after cytoreductive surgery and intraperitoneal chemotherapy for appendiceal adenocarcinoma with peritoneal metastases: A retrospective observational study |
| Q78623138 | Intraoperative modality of treatment for peritoneal carcinomatosis: use of hyperthermic interperitoneal chemoperfusion |
| Q39724374 | Intraoperative near-infrared image-guided surgery for peritoneal carcinomatosis in a preclinical experimental model |
| Q39491271 | Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: an experimental study. |
| Q104058134 | Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Oxaliplatin as Induction Therapy for Patients with Advanced Gastric Cancer with Peritoneal Metastases |
| Q94688556 | Intraperitoneal CMP-001: A Novel Immunotherapy for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer |
| Q89998838 | Intraperitoneal administration of biocompatible hyaluronic acid hydrogel containing multi-chemotherapeutic agents for treatment of colorectal peritoneal carcinomatosis |
| Q39526281 | Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer |
| Q92618060 | Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis - a phase I first-in-human study |
| Q84118656 | Intraperitoneal and intravenous chemotherapy in peritoneal carcinomatosis |
| Q36767967 | Intraperitoneal chemo-hyperthermia in the treatment of peritoneal carcinomatosis of ovarian origin. Initial cases, physiopathologic data |
| Q77869169 | Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis |
| Q80136660 | Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin |
| Q73253231 | Intraperitoneal chemohyperthermia for peritoneal carcinomatosis: original modeling, clinical tolerance and results study about 30 patients |
| Q79121171 | Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures |
| Q73911285 | Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis |
| Q38152303 | Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: review of animal models |
| Q38203730 | Intraperitoneal chemotherapy against peritoneal carcinomatosis: current status and future perspective |
| Q39014341 | Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review |
| Q41741362 | Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis |
| Q35678364 | Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review |
| Q90069151 | Intraperitoneal chemotherapy for gastric cancer with peritoneal metastases: A single center retrospective analysis of 71 patients |
| Q89953619 | Intraperitoneal chemotherapy for locally advanced gastric cancer to prevent and treat peritoneal carcinomatosis |
| Q90358906 | Intraperitoneal chemotherapy for pancreatic cancer with peritoneal metastases: A single center retrospective analysis of 25 patients |
| Q37987772 | Intraperitoneal chemotherapy for peritoneal carcinomatosis from colonic or appendiceal cystadenocarcinoma: rationale and results of treatment |
| Q95401958 | Intraperitoneal chemotherapy for peritoneal carcinomatosis improves efficacy with acceptable safety: results of 200 cycles for 41 patients |
| Q92213942 | Intraperitoneal chemotherapy for peritoneal metastases using sustained release formula of cisplatin-incorporated gelatin hydrogel granules |
| Q90109019 | Intraperitoneal chemotherapy for peritoneal metastases: an expert opinion |
| Q72786644 | Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis |
| Q48830395 | Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2 recirculation using the closed abdomen technique (PRS-1.0 Combat): A clinical pilot study. |
| Q37594150 | Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. |
| Q40100248 | Intraperitoneal chemotherapy with hydroxycamptothecin reduces peritoneal carcinomatosis: results of an experimental study |
| Q46912280 | Intraperitoneal chemotherapy with oxaliplatin after complete cytoreduction for peritoneal carcinomatosis from colorectal carcinoma: preliminary experience |
| Q77719750 | Intraperitoneal contrast material combined with CT for detection of peritoneal metastases of ovarian cancer |
| Q70184891 | Intraperitoneal contrast material improves the CT detection of peritoneal metastases |
| Q91278757 | Intraperitoneal delivery of chemotherapeutic agents for the treatment of peritoneal metastases: current challenges and how to overcome them |
| Q89953641 | Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy/hyperthermic intraperitoneal chemotherapy in gastric cancer |
| Q96607453 | Intraperitoneal hyperthermic chemotherapy after cytoreduction in patients with peritoneal metastases from endometrial cancer. The next frontier? |
| Q79926869 | Intraperitoneal hyperthermic chemotherapy as treatment of peritoneal carcinomatosis of colorectal cancer |
| Q57451001 | Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases |
| Q37583764 | Intraperitoneal immunotherapy to prevent peritoneal carcinomatosis in patients with advanced gastrointestinal malignancies |
| Q37706662 | Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis |
| Q33447398 | Intraperitoneal mitomycin C in the treatment of peritoneal carcinomatosis following second-look surgery |
| Q80525690 | Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma |
| Q73614285 | Intraperitoneal radioimmunotherapy in treating peritoneal carcinomatosis of colon cancer in mice compared with systemic radioimmunotherapy |
| Q99361375 | Intraperitoneal splenosis mimics peritoneal carcinomatosis of leiomyosarcoma and ovarian cancer |
| Q40627865 | Intraperitoneal treatment using taxol is effective for experimental peritoneal carcinomatosis in a rat model |
| Q40404008 | Intraperitoneal treatment with dimethylthioampal (DIMATE) combined with surgical debulking is effective for experimental peritoneal carcinomatosis in a rat model |
| Q46868508 | Intraperitoneal versus intravenous CPT-11 given intra- and postoperatively for peritoneal carcinomatosis in a rat model |
| Q93335726 | Intratumoral Heterogeneity Accounts for Apparent Progression of Noninvasive Serous Tumors to Invasive Low-grade Serous Carcinoma: A Study of 30 Low-grade Serous Tumors of the Ovary in 18 Patients With Peritoneal Carcinomatosis |
| Q39643370 | Investigation of Tumor–Peritoneal Interactions in the Pathogenesis of Peritoneal Metastases using a Novel Ex Vivo Peritoneal Model1 |
| Q69662135 | Involvement of effector cells in the treatment with endotoxins of peritoneal carcinomatosis induced by colon tumour cells |
| Q89992251 | Iodine overlays to improve differentiation between peritoneal carcinomatosis and benign peritoneal lesions |
| Q91699500 | Is ascites CEA a risk factor for peritoneal carcinomatosis in colorectal cancer?: a long-term follow-up study |
| Q77788531 | Is peritoneal carcinomatosis an incurable disease or controllable locoregional condition?--Challenge of surgeons with intraperitoneal hyperthermic chemotherapy |
| Q44522396 | Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? |
| Q30627372 | Is there a role for intraperitoneal administration of heparin in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal cancer origin? Current data and future orientations |
| Q89051244 | Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study |
| Q87081012 | Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively |
| Q42123965 | Isolated Non-ascitic Peritoneal Carcinomatosis from Metastatic Prostate Cancer |
| Q100993332 | Isolated non-ascitic peritoneal carcinomatosis after robotic radical prostatectomy for prostate cancer: A case report |
| Q38090610 | Isolated peritoneal carcinomatosis from gastrointestinal tract carcinoid tumor: two case reports and a review of the literature |
| Q58787943 | Isolated peritoneal carcinomatosis from metastatic castration-resistant prostate cancer and associated biliary obstruction: A case report |
| Q62711166 | Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Peritoneal Metastases |
| Q34003396 | Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases |
| Q90564411 | Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience |
| Q53361170 | KAP1 is associated with peritoneal carcinomatosis in gastric cancer. |
| Q84969383 | KRAS status in patients with colorectal cancer peritoneal carcinomatosis and its impact on outcome |
| Q92124232 | Krukenberg Tumor in Association with Ureteral Stenosis Due to Peritoneal Carcinomatosis from Pulmonary Adenocarcinoma: A Case Report |
| Q81564428 | Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis |
| Q54119202 | Laparo-endoscopic single site surgery for peritoneal carcinomatosis detection and staging (with video). |
| Q95539729 | Laparoendoscopic single-site surgery for the assessment of peritoneal carcinomatosis resectability in patients with advanced ovarian cancer |
| Q48554536 | Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases |
| Q91729277 | Laparoscopic Hyperthermic Intraperitoneal Chemotherapy for Patients with Gastric Peritoneal Metastases: Limitations and Perspectives |
| Q91214334 | Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy |
| Q54398978 | Laparoscopic cytoreductive surgery and early postoperative intraperitoneal chemotherapy for patients with colorectal cancer peritoneal carcinomatosis: initial results from a single center. |
| Q49887578 | Laparoscopic exploration for peritoneal carcinomatosis: Surgical technique |
| Q40252058 | Laparoscopic fluorescence diagnosis of peritoneal metastases from human hepatoblastoma in nude rats |
| Q34005265 | Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer |
| Q83205034 | Laparoscopic hyperthermic intraperitoneal chemotherapy for the management of advanced peritoneal carcinomatosis |
| Q43971153 | Laparoscopic observation of the diaphragm undersurface in the staging of peritoneal carcinomatosis: comparison of three optical systems |
| Q47197797 | Laparoscopy as a useful selection tool for patients with prior surgery and peritoneal metastases suitable for multimodality treatment strategies |
| Q90507699 | Large Cell Neuroendocrine Carcinoma of the Colon With Carcinomatosis Peritonei |
| Q45753142 | Large volume intraperitoneal chemotherapy as treatment for the peritoneal carcinomatosis from gastric cancer |
| Q71797532 | Leiomyomatosis peritonealis disseminata. Report on two cases and differential diagnosis with peritoneal metastases of a low-grade stromal sarcoma of the ovary |
| Q37012644 | Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis |
| Q41715552 | Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer |
| Q72383950 | Liposomal mitoxantrone for the local treatment of peritoneal carcinomatosis induced by colon cancer cells in mice |
| Q87807284 | Liver, lung and peritoneal metastases in colorectal cancers: is the patient still curable? What should the radiologist know |
| Q92305968 | Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging |
| Q33685892 | Local modulated electro-hyperthermia in combination with traditional Chinese medicine vs. intraperitoneal chemoinfusion for the treatment of peritoneal carcinomatosis with malignant ascites: A phase II randomized trial |
| Q41240289 | Localized peritoneal carcinomatosis mimicking an irreducible left inguinal hernia |
| Q92679091 | Locally advanced prostate cancer with peritoneal carcinomatosis causing large bowel obstruction |
| Q45253143 | Locoreginal radioimmunotherapy with 186Re-labeled monoclonal antibody in treating small peritoneal carcinomatosis of colon cancer in mice in comparison with 131I-counterpart |
| Q92856658 | Locoregional peritoneal hyperthermia to enhance the effectiveness of chemotherapy in patients with peritoneal carcinomatosis: a simulation study comparing different locoregional heating systems |
| Q37252040 | Locoregional treatment of peritoneal carcinomatosis from gastric cancer |
| Q92243845 | Long term survival analysis after hyperthermic intraperitoneal chemotherapy with oxaliplatin as a treatment for appendiceal peritoneal carcinomatosis |
| Q34277939 | Long-term results and prognostic factors of gastric cancer patients with microscopic peritoneal carcinomatosis |
| Q90022378 | Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer |
| Q93265900 | Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: A nationwide comparative study |
| Q34286635 | Long-term survival after two surgical resections of peritoneal metastases from hepatocellular carcinoma with an interval of 4 years |
| Q38372400 | Long-term survival of a recurrent gallbladder carcinoma patient with lymph node and peritoneal metastases after multidisciplinary treatments: a case report |
| Q81645274 | Long-term survival of peritoneal carcinomatosis of colorectal origin |
| Q26849259 | Looking up: Recent advances in understanding and treating peritoneal carcinomatosis |
| Q64090054 | Loss of Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases |
| Q35574506 | Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA |
| Q50093235 | Lysophosphatidic Acid is a Biomarker for Peritoneal Carcinomatosis of Gastric Cancer and Correlates with Poor Prognosis |
| Q53246838 | MDP uptake in peritoneal carcinomatosis and Krukenberg tumors from mucinous adenocarcinoma. |
| Q83953046 | MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis |
| Q93085380 | Magnetic Resonance Assessment of Peritoneal Carcinomatosis: Is There a True Benefit From Diffusion-Weighted Imaging? |
| Q50530937 | Malignant Bowel Obstruction in Relapsed Ovarian Cancer With Peritoneal Carcinomatosis: An Occlusive State. |
| Q104457432 | Malignant eosinophilic ascites due to metastatic urothelial carcinoma with peritoneal carcinomatosis |
| Q49796987 | Malignant hydrocele: a rare manifestation of peritoneal carcinomatosis of colorectal origin as a transcoelomic spread into the scrotum - case report and literature overview. |
| Q40099131 | Malignant ovarian teratoma with mature glial peritoneal metastases (author's transl) |
| Q96815921 | Management of Peritoneal Carcinomatosis With Cytoreductive Surgery Combined With Intraperitoneal Chemohyperthermia at a Novel Italian Center |
| Q79121148 | Management of Peritoneal Carcinomatosis: Is an Answer at Hand? |
| Q92991384 | Management of colorectal peritoneal metastases: Expert opinion |
| Q38198598 | Management of diaphragmatic peritoneal carcinomatosis: surgical anatomy guidelines and results |
| Q37910396 | Management of peritoneal carcinomatosis from colorectal cancer |
| Q37531814 | Management of peritoneal carcinomatosis from colorectal cancer: current state of practice. |
| Q38219220 | Management of peritoneal carcinomatosis from colorectal cancer: review of the literature |
| Q40912034 | Management of peritoneal carcinomatosis of unknown primary tumor site |
| Q37328385 | Management of peritoneal carcinomatosis secondary to metastatic cancer of unknown primary in men. |
| Q38519351 | Management of peritoneal metastases - Basic concepts. |
| Q40861533 | Mapping the location of peritoneal metastases using the peritoneal cancer index and the correlation with overall survival: a retrospective study |
| Q40938892 | Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats |
| Q54270019 | Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET. |
| Q71600190 | Mechanism and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to carbon particles |
| Q69737418 | Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis |
| Q73466993 | Medical treatment for peritoneal carcinomatosis from colorectal cancer |
| Q94590108 | Medium-throughput drug screening of patient-derived organoids from colorectal peritoneal metastases to direct personalized therapy |
| Q38804481 | Mesenchymal Stem Cells Engineered to Secrete Pigment Epithelium-Derived Factor Inhibit Tumor Metastasis and the Formation of Malignant Ascites in a Murine Colorectal Peritoneal Carcinomatosis Model |
| Q80434077 | Mesenteric angiosarcoma presenting as a peritoneal carcinomatosis in an 18-month-old girl |
| Q104286087 | Mesenteric desmoid tumors masquerading as peritoneal carcinomatosis |
| Q44539973 | Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo |
| Q91062282 | Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases |
| Q96683448 | Metachronous Development of Peritoneal Carcinomatosis in a Patient with Autoimmune Pancreatitis |
| Q54671416 | Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC. |
| Q86631655 | Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer |
| Q96688648 | Metastatic Colorectal Cancers with Mismatch Repair Deficiency Result in Worse Survival Regardless of Peritoneal Metastases |
| Q74062512 | Metastatic pattern of CC531 colon carcinoma cells in the abdominal cavity: an experimental model of peritoneal carcinomatosis in rats |
| Q87600544 | Methodological flaws of the best evidence on cytoreductive surgery and intraperitoneal chemotherapy in peritoneal carcinomatosis of colorectal cancer |
| Q91594427 | Methylnaltrexone is safe in cancer patients with peritoneal carcinomatosis |
| Q110659663 | MiR-29b may suppresses peritoneal metastases through inhibition of the mesothelial-mesenchymal transition (MMT) of human peritoneal mesothelial cells |
| Q49335244 | Microscopic peritoneal carcinomatosis in gastric cancer: Prevalence, prognosis and predictive factors |
| Q51437300 | Mid-abdominal bulging after breast reconstruction due to peritoneal carcinomatosis of advanced gastric adenocarcinoma. |
| Q93006481 | Model-based analysis of treatment effects of paclitaxel microspheres in a microscopic peritoneal carcinomatosis model in mice |
| Q46793061 | Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy |
| Q57108862 | Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin |
| Q96581399 | Molecular Imaging of Peritoneal Carcinomatosis in Ovarian Carcinoma |
| Q57172926 | Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review |
| Q87821338 | Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study |
| Q79502092 | Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis |
| Q84338404 | Morbidity and mortality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis |
| Q51628648 | Mucinous gastric carcinoma with abdominal carcinomatosis and hypergastrinemia in a dog. |
| Q46761460 | Multi-detector CT in peritoneal carcinomatosis: diagnostic role of thin slices and multiplanar reconstructions |
| Q52662126 | Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study. |
| Q38350132 | Multidetector CT detection of peritoneal metastases: evaluation of sensitivity between standard 2.5 mm axial imaging and maximum-intensity-projection (MIP) reconstructions |
| Q35124938 | Multidetector CT of Peritoneal Carcinomatosis from Ovarian Cancer |
| Q88718421 | Multidetector Computed Tomography Versus Staging Laparoscopy for the Detection of Peritoneal Metastases in Esophagogastric Junctional and Gastric Cancer |
| Q104493893 | Multidetector computed tomography in diagnosing peritoneal metastases in ovarian carcinoma |
| Q37571642 | Multidisciplinary Treatment for Colorectal Peritoneal Metastases: Review of the Literature |
| Q34390124 | Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer |
| Q36673709 | Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulation |
| Q50898941 | Multimodal oncosurgery approach to treat peritoneal carcinomatosis in a patient with occlusive ovarian carcinoma. |
| Q34209903 | Multimodal treatment of peritoneal carcinomatosis and sarcomatosis. |
| Q51916441 | Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies. |
| Q26769938 | Multimodality treatment strategies have changed prognosis of peritoneal metastases |
| Q72148433 | Multiple glove powder granulomas masquerading as peritoneal carcinomatosis |
| Q92571327 | Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response |
| Q40346118 | NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine |
| Q38898633 | Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis - Mission possible? |
| Q28395895 | Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis |
| Q64983651 | Narrow-Band Imaging Improves Detection of Colorectal Peritoneal Metastases: A Clinical Study Comparing Advanced Imaging Techniques. |
| Q36882738 | Natural history of peritoneal carcinomatosis from digestive origin. |
| Q35563265 | Natural history of peritoneal carcinomatosis from nongynecologic malignancies. |
| Q42926742 | Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin |
| Q52642383 | Neoadjuvant intraperitoneal chemotherapy followed by radical surgery and HIPEC in patients with very advanced gastric cancer and peritoneal metastases: report of an initial experience in a western single center. |
| Q83887346 | Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study |
| Q91454066 | Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: A retrospective cohort study |
| Q86423600 | Neuroendocrine carcinomas: optimal surgery of peritoneal metastases (and associated intra-abdominal metastases) |
| Q45243526 | Neutrophil dynamics in peritoneal carcinomatosis patients treated with cytoreductive surgery and hyperthermic intraperitoneal oxaliplatin |
| Q38765795 | Ninety percent of the adverse outcomes occur in 10% of patients: can we identify the populations at high risk of developing peritoneal metastases after curative surgery for colorectal cancer? |
| Q83812232 | No-incision (NOTES) versus single-incision (single-port) surgery for access to sites of peritoneal carcinomatosis: a back-to-back animal study |
| Q86893508 | Non-Hodgkin lymphoma mimicking pancreatic adenocarcinoma and peritoneal carcinomatosis |
| Q36025789 | Non-invasive imaging of implanted peritoneal carcinomatosis in mice using PET and bioluminescence imaging |
| Q40186194 | Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after 213Bi-radioimmunotherapy using bioluminescence imaging |
| Q96224396 | Non-neoplastic conditions mimicking peritoneal carcinomatosis at CT imaging |
| Q44101953 | Non-surgical treatment for afferent loop syndrome in recurrent gastric cancer complicated by peritoneal carcinomatosis: percutaneous transhepatic duodenal drainage followed by 24-hour infusion of high-dose fluorouracil and leucovorin |
| Q35509695 | Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis |
| Q99202695 | Novel Application of Iterative Hyperthermic Intraperitoneal Chemotherapy for Unresectable Peritoneal Metastases from High-Grade Appendiceal Ex-Goblet Adenocarcinoma |
| Q90226372 | Novel prognostic score for outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with metachronous peritoneal carcinomatosis |
| Q89947200 | Novel, genetically induced mouse model that recapitulates the histological morphology and immunosuppressive tumor microenvironment of metastatic peritoneal carcinomatosis |
| Q41572946 | Octreotide (SMS 201-995) inhibits the growth of colon peritoneal carcinomatosis in BDIX rats |
| Q91711362 | Omental Tissue-Mediated Tumorigenesis of Gastric Cancer Peritoneal Metastases |
| Q24611077 | Omental inflammatory myofibroblastic tumour mimicking peritoneal carcinomatosis |
| Q102074964 | Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer |
| Q34962518 | Oncosuppressive suicide gene virotherapy "PVH1-yCD/5-FC" for pancreatic peritoneal carcinomatosis treatment: NFκB and Akt/PI3K involvement |
| Q83357111 | Optical diagnosis of peritoneal metastases by infrared microscopic imaging |
| Q35761049 | Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis |
| Q58566712 | Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis |
| Q35954086 | Oral gastrografin radiography for the evaluation of the functional impact of peritoneal carcinomatosis: Correlation with clinicopathological findings |
| Q42937136 | Oral glutamine supplement inhibits ascites formation in peritoneal carcinomatosis mouse model. |
| Q51808589 | Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC. |
| Q92737596 | Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy |
| Q39637827 | Orthotopic fluorescent peritoneal carcinomatosis model of esophageal cancer |
| Q58806095 | Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis |
| Q30719628 | Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan |
| Q26774607 | Outcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastases |
| Q90803636 | Outcome in Patients Treated With Cytoreductive Surgery and HIPEC for Gastric Cancer With Peritoneal Carcinomatosis |
| Q45958054 | Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. |
| Q90915553 | Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) |
| Q47787166 | Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. |
| Q96029804 | Outcomes of cytoreductive operations for peritoneal carcinomatosis with or without liver cytoreduction in patients with small bowel neuroendocrine tumors |
| Q84584426 | Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis |
| Q84452101 | Ovarian cancer screening and peritoneal carcinomatosis: standards, 'omics' and miRNAs for personalized management |
| Q33895603 | Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis |
| Q90731964 | Overall clinical and trichoscopic analysis performed in patients who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis - initial trial preliminary report |
| Q39140018 | Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery |
| Q39755621 | Oxaliplatin for chemotherapeutic treatment and prevention of experimental peritoneal carcinomatosis in rats comparing the intraperitoneal and intravenous application mode |
| Q91348584 | Oxaliplatin versus Mitomycin C following complete cytoreduction for colorectal peritoneal metastases: a comparative study |
| Q88624858 | Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis |
| Q92480632 | P.R.O.P.S. - A novel Pre-Operative Predictive Score for unresectability in patients with colorectal peritoneal metastases being considered for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) |
| Q46920561 | PET or PET/CT for detection of peritoneal carcinomatosis: a meta-analysis |
| Q37606388 | PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum |
| Q88262048 | PIPAC puts pressure on peritoneal metastases from pancreatic cancer |
| Q101225398 | PIPAC-OX: A Phase I study of Oxaliplatin-based Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Peritoneal Metastases |
| Q36789605 | PNEUMATOSIS CYSTOIDES INTESTINALIS ASSOCIATED WITH ABDOMINAL CARCINOMATOSIS |
| Q40828751 | PREDICTORS OF PERITONEAL CARCINOMATOSIS IN PATIENTS WITH COLORECTAL CANCER |
| Q97894912 | PROPHYLOCHIP: no benefit of second-look surgery plus HIPEC for colorectal peritoneal metastases |
| Q37767227 | Paclitaxel and carboplatin-induced complete remission in peritoneal carcinomatosis of unknown origin: a report of two cases and review of the literature |
| Q53846781 | Paclitaxel/carboplatin versus cyclophosphamide/carboplatin in peritoneal carcinomatosis of the ovary. |
| Q89214716 | Palliative Management of Advanced Peritoneal Carcinomatosis |
| Q85312871 | Palliative interventions in patients with peritoneal metastases and malignant bowel obstruction |
| Q100519758 | Palliative treatment for malignant gastrointestinal obstruction with peritoneal carcinomatosis: enteral stenting versus surgery |
| Q81913693 | Pancreatic mucinous adenocarcinoma with peritoneal metastases |
| Q89953629 | Pancreatic neuroendocrine cancer with liver metastases and multiple peritoneal metastases: report of one case |
| Q69794177 | Papillary cystadenocarcinoma of the appendiceal stump with mucocele and peritoneal metastases |
| Q44900081 | Papillary peritoneal carcinomatosis after prophylactic oophorectomy |
| Q39080592 | Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer. |
| Q89925204 | Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases |
| Q35984178 | Patent blue V and indocyanine green for fluorescence microimaging of human peritoneal carcinomatosis using probe-based confocal laser endomicroscopy |
| Q71600165 | Pathobiology of peritoneal carcinomatosis from ovarian malignancy |
| Q73348268 | Pathogenesis of ascites in peritoneal carcinomatosis |
| Q90786604 | Pathological complete response after intraperitoneal paclitaxel and systemic combined chemotherapy in a patient with peritoneal metastases from gastric cancer: a case report |
| Q34391039 | Pathophysiology and biology of peritoneal carcinomatosis |
| Q28073129 | Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum |
| Q41108307 | Pathophysiology of elevated ascites fluid cholesterol in malignant ascites. Increased ascites to serum relation of proteins and lipoproteins in patients with peritoneal carcinomatosis as compared to patients with cirrhosis of the liver |
| Q39014295 | Pathway of peritoneal carcinomatosis maybe hematogenous metastasis rather than peritoneal seeding |
| Q40527934 | Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer |
| Q39442876 | Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer |
| Q50945368 | Patient selection for cytoreductive surgery in colorectal peritoneal carcinomatosis using serum tumor markers: an observational cohort study. |
| Q53213677 | Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility? |
| Q98889540 | Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q93235451 | Patients with extensive regional lymph node involvement (pN2) following potentially curative surgery for colorectal cancer are at increased risk for developing peritoneal metastases: a retrospective single-institution study |
| Q54352137 | Patients with nonovarian peritoneal carcinomatosis achieve long-term survival. |
| Q87425387 | Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer |
| Q84531351 | Peculiar recurrence of malignant melanoma: metastases on cutaneous scars and peritoneal carcinomatosis |
| Q72324180 | Pediatric radiology case of the day. Peritoneal carcinomatosis |
| Q99729226 | Pelvic Exenteration combined with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Advanced Primary or Recurrent Colorectal Cancer with Peritoneal Metastases |
| Q44367062 | Pelvic-peritoneal tuberculosis simulating peritoneal carcinomatosis: high clinical suspicion and a minimally invasive procedure |
| Q91676659 | Perceptions in the management of colorectal peritoneal metastases: A bi-national survey of colorectal surgeons |
| Q80255754 | Percutaneous transesophageal gastrotubing was effective in palliating major symptoms of a patient with peritoneal carcinomatosis |
| Q99731992 | Perioperative FOLFOX in management of peritoneal metastases of colorectal cancer. Case report of 2 patients |
| Q91650239 | Perioperative Management for Colorectal Peritoneal Metastases |
| Q44806071 | Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database |
| Q61182945 | Perioperative systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q64087322 | Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, r |
| Q39287839 | Perioperative systemic therapy for resectable colorectal peritoneal metastases: Sufficient evidence for its widespread use? A critical systematic review |
| Q90355592 | Peritoneal Carcinomatosis Arising from Primary Anorectal Melanoma |
| Q92462018 | Peritoneal Carcinomatosis Diagnosis and Treatment in China: Focusing on Training and Collaboration |
| Q58088279 | Peritoneal Carcinomatosis From Yolk Sac Tumor in a Postmenopausal Woman Following Chemotherapy for High-grade Ovarian Serous Carcinoma |
| Q50121512 | Peritoneal Carcinomatosis Presenting as a Sister Mary Joseph Nodule |
| Q91881846 | Peritoneal Carcinomatosis Risk and Long-Term Survival Following Hepatectomy for Spontaneous Hepatocellular Carcinoma Rupture: Results of a Multicenter French Study (FRENCH-AFC) |
| Q88718086 | Peritoneal Carcinomatosis Targeting with Tumor Homing Peptides |
| Q89561025 | Peritoneal Carcinomatosis and Its Mimics: Review of CT Findings for Differential Diagnosis |
| Q31031044 | Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal Chemotherapy |
| Q90698090 | Peritoneal Carcinomatosis from Ovarian Cancer - Current Clinical Impact of Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy |
| Q51153139 | Peritoneal Carcinomatosis in Colorectal Cancers - Management Perspective Needs a Change. |
| Q88394145 | Peritoneal Carcinomatosis in Primary Ovarian Cancer: Ultrasound Detection and Comparison with Computed Tomography |
| Q93168133 | Peritoneal Carcinomatosis in Well-Differentiated Small-Intestinal Neuroendocrine Tumors with Mesenteric Tumor Deposits |
| Q95275793 | Peritoneal Carcinomatosis in an Adult With Sjögren's Syndrome: A Diagnostic Dilemma Revealing a Rare Association With Primary Gastric Adenocarcinoma |
| Q96021603 | Peritoneal Carcinomatosis of Colorectal Origin in Cyclosporine Immunosuppressed Rats |
| Q57779529 | Peritoneal Carcinomatosis of Colorectal Origin: Standard of Care |
| Q90698086 | Peritoneal Carcinomatosis of Gastric Origin - Treatment Possibilities |
| Q64045907 | Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE |
| Q48536546 | Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients |
| Q56112361 | Peritoneal Carcinomatosis: Pictorial Review of Computed Tomography Findings |
| Q104682569 | Peritoneal Lavage Cytology Following Neoadjuvant Chemotherapy for Gastric Adenocarcinoma: Low Yield in Detecting Peritoneal Metastases |
| Q64092854 | Peritoneal Lymphomatosis Mimicking Peritoneal Carcinomatosis from Ovarian Malignancy on F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography |
| Q89214697 | Peritoneal Metastases from Appendiceal Cancer |
| Q90681958 | Peritoneal Metastases from Breast Cancer: A Scoping Review |
| Q89214706 | Peritoneal Metastases from Colorectal Cancer: Treatment Principles and Perspectives |
| Q88792425 | Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors |
| Q38958621 | Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis. |
| Q89047880 | Peritoneal Metastases from Gastrointestinal Cancer |
| Q89214387 | Peritoneal Metastases from Malignant Mesothelioma |
| Q88635056 | Peritoneal Metastases in Colorectal Cancer |
| Q91348465 | Peritoneal Metastases in Colorectal Cancer: Biology and Barriers |
| Q91526892 | Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells |
| Q89214362 | Peritoneal Metastases, a Frontier for Progress |
| Q39810853 | Peritoneal Metastases: Prevention and Treatment |
| Q88029237 | Peritoneal Pulse Granulomas With Spiral Bodies Mimicking Peritoneal Carcinomatosis: A Case Report |
| Q29040011 | Peritoneal Sarcomatosis Versus Peritoneal Carcinomatosis: Imaging Findings at MDCT |
| Q90269823 | Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect? |
| Q37946808 | Peritoneal carcinomatosis 2011; it's about time for chemosurgery. |
| Q83176581 | Peritoneal carcinomatosis after laparoscopic radical hysterectomy for early-stage cervical adenocarcinoma |
| Q44334829 | Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome |
| Q47189965 | Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers. |
| Q87123111 | Peritoneal carcinomatosis and Courvoisier gallbladder |
| Q79227288 | Peritoneal carcinomatosis and hepatic infiltration related to the dissemination of a micropapillary cell carcinoma of the bladder |
| Q37562100 | Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection |
| Q74297267 | Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma |
| Q87300940 | Peritoneal carcinomatosis and prostatic cancer: a rare manifestation of the disease with an impact on management |
| Q71636548 | Peritoneal carcinomatosis and radioimmunoguided surgery |
| Q53408158 | Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases. |
| Q37853533 | Peritoneal carcinomatosis cytoreductive surgery and HIPEC: a ray of hope for cure. |
| Q72180148 | Peritoneal carcinomatosis due to transitional cell carcinoma of the bladder: CT findings in two patients |
| Q73463136 | Peritoneal carcinomatosis following laparoscopic resection of an adrenocortical tumor causing primary hyperaldosteronism |
| Q76223452 | Peritoneal carcinomatosis forty-one years after radical mastectomy |
| Q35128431 | Peritoneal carcinomatosis from a small bowel carcinoid tumour |
| Q71140778 | Peritoneal carcinomatosis from adenocarcinoma of the colon |
| Q71600204 | Peritoneal carcinomatosis from adenocarcinoma of the colon |
| Q74007090 | Peritoneal carcinomatosis from an unknown primary site. Management of 15 patients |
| Q83845864 | Peritoneal carcinomatosis from appendiceal cancer: early adequate therapeutic management for long-term survival |
| Q70623455 | Peritoneal carcinomatosis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy |
| Q44907178 | Peritoneal carcinomatosis from cervical cancer detected by F-18 FDG positron emission tomography |
| Q78553388 | Peritoneal carcinomatosis from colorectal cancer |
| Q36503851 | Peritoneal carcinomatosis from colorectal cancer and small bowel cancer treated with peritonectomy |
| Q98953650 | Peritoneal carcinomatosis from colorectal cancer in the pediatric population: Cytoreductive surgery and HIPEC. A systematic review |
| Q37079040 | Peritoneal carcinomatosis from colorectal cancer: HIPEC? |
| Q82060181 | Peritoneal carcinomatosis from colorectal cancer: The need for improving selection criteria for cytoreductive surgery and intraperitoneal chemotherapy |
| Q35757869 | Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement |
| Q35721975 | Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia |
| Q83903423 | Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy |
| Q72113191 | Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management |
| Q73368601 | Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study |
| Q35121648 | Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy |
| Q78093874 | Peritoneal carcinomatosis from ovarian cancer: cytoreductive surgery and intraperitoneal chemotherapy |
| Q43270458 | Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT. |
| Q93029582 | Peritoneal carcinomatosis from ovarian carcinoma treated by interval laparoscopic complete cytoreduction and HIPEC with extraction through natural orifice |
| Q42621684 | Peritoneal carcinomatosis from ovarian epithelial primary: combined aggressive treatment. |
| Q89441501 | Peritoneal carcinomatosis from ovarian paraganglioma: Report of a rare case and systematic review of the literature |
| Q81376008 | Peritoneal carcinomatosis from ruptured hepatocellular carcinoma on bone scintigraphy |
| Q87620333 | Peritoneal carcinomatosis from signet-ring cell adenocarcinoma of the appendix |
| Q41746463 | Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling. |
| Q83594617 | Peritoneal carcinomatosis from solid pseudopapillary neoplasm (Frantz's tumour) of the pancreas treated with HIPEC |
| Q41026488 | Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy? |
| Q93344781 | Peritoneal carcinomatosis in colorectal cancer: Defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - A pilot study |
| Q80115076 | Peritoneal carcinomatosis in digestive cancers: cytoreductive surgery combined with intraperitoneal chemohyperthermia. The experience in Centre Hospitalier et Universitaire Lyon Sud (CHLS) |
| Q99235456 | Peritoneal carcinomatosis in gastric cancer: Are Hispanics at higher risk? |
| Q93101700 | Peritoneal carcinomatosis in gastro-entero-pancreatic neuroendocrine neoplasms: clinical impact and effectiveness of the available therapeutic options |
| Q73096729 | Peritoneal carcinomatosis in germ-cell tumor: relations with retroperitoneal lymph node dissection |
| Q46654953 | Peritoneal carcinomatosis in lung cancer |
| Q74628451 | Peritoneal carcinomatosis in lung cancer patients |
| Q91218754 | Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review |
| Q69935981 | Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors |
| Q45125749 | Peritoneal carcinomatosis in ovarian cancer. Methods and treatment results |
| Q44765346 | Peritoneal carcinomatosis in patients with digestive endocrine tumors |
| Q39326692 | Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy |
| Q53124074 | Peritoneal carcinomatosis in patients with ovarian cancer: enhanced CT versus 18F-FDG PET/CT. |
| Q38382061 | Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI, and 18F-FDG PET/CT. |
| Q79754063 | Peritoneal carcinomatosis in refractory seminoma |
| Q45917079 | Peritoneal carcinomatosis in t4 colorectal cancer: occurrence and risk factors. |
| Q53414566 | Peritoneal carcinomatosis in urinary bladder cancer. |
| Q54941671 | Peritoneal carcinomatosis index as a predictor of diaphragmatic involvement in stage III and IV ovarian cancer. |
| Q64055171 | Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study |
| Q42643827 | Peritoneal carcinomatosis is less frequently diagnosed during laparoscopic surgery compared to open surgery in patients with colorectal cancer. |
| Q90700639 | Peritoneal carcinomatosis is multifaceted, treatment requires expertise and collaboration with other health care personnel: New avenues of research are open |
| Q38207035 | Peritoneal carcinomatosis mimicking a perforated diverticulitis |
| Q35003313 | Peritoneal carcinomatosis mimicking a peritoneal tuberculosis |
| Q51467202 | Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors. |
| Q42149012 | Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells |
| Q35211565 | Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities |
| Q39212979 | Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes |
| Q79317783 | Peritoneal carcinomatosis of colorectal origin |
| Q34391090 | Peritoneal carcinomatosis of colorectal origin. |
| Q36340590 | Peritoneal carcinomatosis of colorectal origin. Current treatment. Review and update. |
| Q42398293 | Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options. |
| Q36375924 | Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies |
| Q85994714 | Peritoneal carcinomatosis of colorectal origin: is it really an end-stage disease? |
| Q40212536 | Peritoneal carcinomatosis of colorectal origin: recent advances and future evolution toward a curative treatment. |
| Q45839982 | Peritoneal carcinomatosis of colorectal origin: results of cytoreductive surgery with peritonectomy and hyperthermic intraoperative chemotherapy |
| Q80336380 | Peritoneal carcinomatosis of colorectal origin: standard of care |
| Q43880060 | Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors |
| Q37528436 | Peritoneal carcinomatosis of gastrointestinal origin: natural history and treatment options |
| Q34366940 | Peritoneal carcinomatosis of gastrointestinal tumors: where are we now? |
| Q69215041 | Peritoneal carcinomatosis of unknown primary site in women. A distinctive subset of adenocarcinoma |
| Q90346780 | Peritoneal carcinomatosis of unknown primary site may be an undiagnosed appendiceal adenocarcinoma. A case series |
| Q94956731 | Peritoneal carcinomatosis of unknown primary site, a study of 25 patients over 30 years |
| Q75410936 | Peritoneal carcinomatosis or liver metastases from colorectal cancer: similar standards for a curative surgery? |
| Q52638974 | Peritoneal carcinomatosis or something else? |
| Q80408065 | Peritoneal carcinomatosis secondary to carcinoid tumour |
| Q87579381 | Peritoneal carcinomatosis secondary to spread of hepatocellular carcinoma originated upon a healthy liver |
| Q45341695 | Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. |
| Q73743195 | Peritoneal carcinomatosis treatment with curative intent: the Institut Gustave-Roussy experience |
| Q70149107 | Peritoneal carcinomatosis with ascites |
| Q40274438 | Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery? |
| Q73707885 | Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma |
| Q36888771 | Peritoneal carcinomatosis, an unusual and only site of metastasis from lung adenocarcinoma |
| Q98770616 | Peritoneal carcinomatosis, unilateral malignant pleural effusion with bilateral hydronephrosis post-radical gastrectomy in a signet-ring gastric cancer patient: a case report |
| Q38542573 | Peritoneal carcinomatosis: A malignant disease with an embryological origin? |
| Q73496107 | Peritoneal carcinomatosis: a final frontier |
| Q58484637 | Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings |
| Q37987561 | Peritoneal carcinomatosis: cytoreductive surgery and HIPEC--overview and basics |
| Q33608172 | Peritoneal carcinomatosis: feature of dissemination. A review. |
| Q34377672 | Peritoneal carcinomatosis: image-guided peritoneal core biopsy for tumor type and patient care |
| Q57944299 | Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging |
| Q43626519 | Peritoneal carcinomatosis: imaging with intraperitoneal injection of I-131-labeled B72.3 monoclonal antibody |
| Q83629648 | Peritoneal carcinomatosis: intra-operative and post-operative assessment of patients undergoing cytoreduction and HIPEC |
| Q35133095 | Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC. |
| Q39246331 | Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy. |
| Q41134502 | Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy |
| Q37090867 | Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q67716930 | Peritoneal carcinomatosis: preoperative CT with intraperitoneal contrast material |
| Q44576343 | Peritoneal carcinomatosis: role of (18)F-FDG PET. |
| Q69597544 | Peritoneal carcinomatosis: the role of debulking procedures |
| Q75216747 | Peritoneal carcinomatosis: what can we do about it? |
| Q33753340 | Peritoneal location of fascioliasis mimicking a peritoneal carcinomatosis |
| Q52982961 | Peritoneal lymphomatosis confused with peritoneal carcinomatosis due to the previous history of gastric cancer: a case report. |
| Q45935810 | Peritoneal lymphomatosis mimicking peritoneal carcinomatosis: important imaging clues for correct diagnosis. |
| Q83738087 | Peritoneal lymphomatosis, a morphological look alike to peritoneal carcinomatosis: an autopsy report |
| Q59103953 | Peritoneal metastases after laparoscopic nephron-sparing surgery for localized Wilms tumor |
| Q51745192 | Peritoneal metastases from adrenal cortical carcinoma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. |
| Q79967953 | Peritoneal metastases from an atypical fibroxanthoma |
| Q38117934 | Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. |
| Q91111704 | Peritoneal metastases from extra-abdominal cancer - A population-based study |
| Q92533064 | Peritoneal metastases from malignant degeneration of ectopic gastric epithelium in Meckel's diverticulum: A case report |
| Q40743658 | Peritoneal metastases from mucinous endocervical adenocarcinoma. |
| Q42668231 | Peritoneal metastases from renal cell carcinoma: Images in urology |
| Q41146305 | Peritoneal metastases from small bowel cancer: Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in The Netherlands. |
| Q41685997 | Peritoneal metastases from transitional cell carcinoma of the urinary tract: CT and MR imaging |
| Q74789086 | Peritoneal metastases in children with cancer |
| Q72679678 | Peritoneal metastases in pancreatic carcinoma |
| Q48204725 | Peritoneal metastases in two patients with pineoblastoma and ventriculo-peritoneal shunts |
| Q50049266 | Peritoneal metastases invading the seminal vesicles: Radiologic appearance and outcome of treatment |
| Q96638921 | Peritoneal metastases management: Towards the era of prospective randomized trials? |
| Q50042836 | Peritoneal metastases of colorectal origin - cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). The financial aspect |
| Q38260693 | Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview |
| Q85716971 | Peritoneal metastases of lower gastrointestinal tract origin: a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy |
| Q33838073 | Peritoneal metastases of lower gastrointestinal tract origin:a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy |
| Q41454278 | Peritoneal metastases of rare carcinomas treated with cytoreductive surgery and HIPEC - A single center case series |
| Q38370744 | Peritoneal metastases: challenges for the surgeon |
| Q78069355 | Peritoneal metastases: detection with spiral CT in patients with ovarian cancer |
| Q85225354 | Peritoneal metastases: evaluation with contrast-enhanced ultrasound |
| Q92783690 | Peritoneal sarcoidosis mimicking peritoneal carcinomatosis |
| Q87414790 | Peritoneal splenosis mimicking peritoneal carcinomatosis: a case report |
| Q35143293 | Peritoneal tuberculosis mimicking peritoneal carcinomatosis |
| Q84568662 | Peritoneal tuberculosis mimicking peritoneal carcinomatosis |
| Q71012769 | Peritoneal tuberculosis versus peritoneal carcinomatosis: distinction based on CT findings |
| Q37654602 | Peritoneal tuberculosis with elevated CA-125 mimicking ovarian cancer with carcinomatosis peritonei: Crucial CT findings |
| Q46452227 | Peritoneal tuberculosis with elevated serum CA125 mimicking peritoneal carcinomatosis on F-18 FDG-PET/CT. |
| Q102218792 | Peritoneal well-differentiated papillary mesothelioma coexisting with endometrial adenocarcinoma mimicking peritoneal carcinomatosis: A case report |
| Q82626484 | Peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian peritoneal carcinomatosis: an argued role |
| Q78204909 | Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study |
| Q83239530 | Peritonectomy for peritoneal carcinomatosis: long-term outcomes from a single Brazilian institution |
| Q41045942 | Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center |
| Q61903723 | Phagocytic Activity and Nitric Oxide Production of Circulating Polymorphonuclear Leukocytes from Patients with Peritoneal Carcinomatosis |
| Q34544598 | Pharmacokinetic and pharmacodynamic analysis of hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosis |
| Q77301751 | Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis |
| Q84977873 | Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis |
| Q80379791 | Pharmacokinetics of cisplatin in semi-closed hyperthermic peritoneal perfusion (HPP) for treatment of peritoneal carcinomatosis |
| Q35476298 | Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer |
| Q35563273 | Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis |
| Q82354889 | Pharmacokinetics of mitomycin C after resection of peritoneal carcinomatosis and intraperitoneal chemohyperthermic perfusion |
| Q84966959 | Pharmacokinetics of pegylated liposomal doxorubicin administered by intraoperative hyperthermic intraperitoneal chemotherapy to patients with advanced ovarian cancer and peritoneal carcinomatosis |
| Q92894785 | Pharmacokinetics of the intraperitoneal nanoparticle pegylated liposomal doxorubicin in patients with peritoneal metastases |
| Q39561158 | Pharmacologic downregulation of c-FLIP(L) restores juxtacrine death receptor-mediated apoptosis in cancer cells in a peritoneal carcinomatosis model |
| Q70557956 | Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodents |
| Q40000525 | Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals |
| Q92617937 | Pharmacology of chemotherapy treatments for peritoneal metastases: optimizing and augmenting HIPEC |
| Q59360835 | Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis |
| Q64066802 | Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol |
| Q92618103 | Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rati |
| Q53116372 | Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma. |
| Q36470056 | Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma |
| Q84968275 | Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy |
| Q83730613 | Phase II study of regional treatment for peritoneal carcinomatosis |
| Q30572371 | Photodynamic Detection of Peritoneal Metastases Using 5-Aminolevulinic Acid (ALA). |
| Q99213426 | Photodynamic Diagnosis and Therapy for Peritoneal Carcinomatosis: Emerging Perspectives |
| Q36196629 | Photodynamic diagnosis with 5-aminolevulinic acid for intraoperative detection of peritoneal metastases of ovarian cancer: A feasibility and dose finding study |
| Q27324488 | Photoimmunotherapy of gastric cancer peritoneal carcinomatosis in a mouse model |
| Q79289943 | Pilot study of Flt3 ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas |
| Q85478652 | Pitfalls and mimickers on (18)F-FDG-PET/CT in peritoneal carcinomatosis from colorectal cancer: An analysis from 37 patients |
| Q34570737 | Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis |
| Q33427607 | Platelet Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin |
| Q70619195 | Polypoid peritoneal metastases from carcinoid neoplasms |
| Q85263926 | Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology |
| Q89485986 | Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer |
| Q50111382 | Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgery |
| Q43519546 | Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin |
| Q83465147 | Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy |
| Q37526816 | Port site and peritoneal metastases after laparoscopic cholecystectomy for incidentally found gallbladder carcinoma |
| Q38282363 | Port site and peritoneal metastases after robot-assisted radical prostatectomy |
| Q73168146 | Possible first report of distant peritoneal metastases from a nodal mesenteric lymphoma after laparoscopic inguinal hernia repair |
| Q38320984 | Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers |
| Q42090425 | Post-mortem Findings in Case Shown on October 10, 1930, as one of Abdominal Carcinomatosis with Probable Adrenal Involvement |
| Q102993619 | Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis |
| Q50673198 | Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients. |
| Q42240207 | Postoperative infections after cytoreductive surgery and HIPEC for peritoneal carcinomatosis: proposal and results from a prospective protocol study of prevention, surveillance and treatment |
| Q80817136 | Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis |
| Q53018735 | Postoperative time course and utility of inflammatory markers in patients with ovarian peritoneal carcinomatosis treated with neoadjuvant chemotherapy, cytoreductive surgery, and HIPEC. |
| Q92618023 | Practice patterns, attitudes, and knowledge among physicians regarding cytoreductive surgery and HIPEC for patients with peritoneal metastases |
| Q37701587 | Precise integrin-targeting near-infrared imaging-guided surgical method increases surgical qualification of peritoneal carcinomatosis from gastric cancer in mice |
| Q90754497 | Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer |
| Q92934323 | Predicting Aborted Hyperthermic Intraperitoneal Chemotherapy (AHIPEC) with Preoperative Tumor and Inflammatory Markers in Potentially Resectable Appendiceal Cancer Patients with Peritoneal Carcinomatosis |
| Q44911605 | Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy |
| Q36060534 | Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index. |
| Q50288386 | Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index |
| Q88200195 | Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy |
| Q84396704 | Predictive factors for improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis |
| Q42169679 | Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. |
| Q88578675 | Predictive factors of synchronous colorectal peritoneal metastases: Development of a nomogram and study of its utilities using decision curve analysis |
| Q91185476 | Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis |
| Q44393228 | Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study |
| Q89833679 | Predictors of morbidity and mortality for patients with peritoneal carcinomatosis secondary to colorectal cancer following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q37583729 | Predictors of peritoneal carcinomatosis in patients with gastric cancer treated at a single institution in Brazil. |
| Q46198034 | Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q38040201 | Predictors of survival in patients with high-grade peritoneal metastases undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q54326192 | Preferential HER2 expression in liver metastases and EGFR expression in peritoneal metastases in patients with advanced gastric cancer. |
| Q44817470 | Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin |
| Q41047329 | Preoperative Assessment of Cancer Patients with Peritoneal Metastases for Complete Cytoreduction |
| Q91538526 | Preoperative CA125 value predicts Glisson capsule involvement in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q88424663 | Preoperative CT-based predictive factors for resectability and medium-term overall survival in patients with peritoneal carcinomatosis from colorectal cancer |
| Q89285313 | Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival |
| Q43837760 | Preoperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic intraperitoneal chemotherapy following cytoreductive surgery |
| Q53823054 | Preoperative assessment of peritoneal carcinomatosis of colorectal origin. |
| Q44076876 | Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI. |
| Q90840731 | Preoperative assessment of splenic involvement in patients with peritoneal carcinomatosis with CT and MR imaging |
| Q81484790 | Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q82366764 | Preoperative criteria of incomplete resectability of peritoneal carcinomatosis from non-appendiceal colorectal carcinoma |
| Q34616030 | Preoperative inflammatory biomarkers and neurovegetative symptoms in peritoneal carcinomatosis patients |
| Q92617897 | Preoperative intraperitoneal oxaliplatin for unresectable peritoneal carcinomatosis of colorectal origin: a pilot study |
| Q51161081 | Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. |
| Q53217386 | Preparation of camptothecin-loaded PCEC microspheres for the treatment of colorectal peritoneal carcinomatosis and tumor growth in mice. |
| Q44424534 | Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma |
| Q92743384 | Pressurized IntraPeritoneal Aerosol Chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer - study protocol for a randomized control trial |
| Q47253274 | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Procedure for Non-resectable Peritoneal Carcinomatosis (with Video). |
| Q61816226 | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases in Solid Organ Graft Recipients: First Experience |
| Q91078992 | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) through a single port: alternative delivery for the control of peritoneal metastases |
| Q94515998 | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial |
| Q102214411 | Pressurized Intraperitoneal Aerosol Chemotherapy Enhanced by Electrostatic Precipitation (ePIPAC) for Patients with Peritoneal Metastases |
| Q41072711 | Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study |
| Q92496034 | Pressurized Intraperitoneal Aerosol Chemotherapy, a Palliative Treatment Approach for Patients With Peritoneal Carcinomatosis: Description of Method and Systematic Review of Literature |
| Q88990657 | Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: systematic review of clinical and experimental evidence with special emphasis on ovarian cancer |
| Q90655316 | Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer |
| Q102208705 | Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer |
| Q91330745 | Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview |
| Q61810585 | Pressurized intraperitoneal aerosol chemotherapy procedure for nonresectable peritoneal carcinomatosis: First Indian study |
| Q90533514 | Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept |
| Q92861533 | Prevention and Treatment of Peritoneal Metastases: a Comprehensive Review |
| Q87147403 | Prevention and early treatment of peritoneal metastases from colorectal cancer: second-look laparotomy or prophylactic HIPEC? |
| Q44097797 | Prevention and treatment of peritoneal carcinomatosis in experimental investigations with CPT-11 and oxaliplatin |
| Q79237773 | Prevention of Peritoneal Carcinomatosis from Human Gastric Cancer Cells by Adjuvant-Type Intraperitoneal Immunotherapy in a SCID Mouse Model |
| Q35974935 | Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC. |
| Q31927277 | Prevention of hepatic and peritoneal metastases by the angiogenesis inhibitor fr-118487 after removal of growing tumor in mice |
| Q40566647 | Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice |
| Q86823189 | Prevention of peritoneal carcinomatosis from colorectal cancer: a critical issue |
| Q82335895 | Prevention of peritoneal carcinomatosis in mice by combining hyperthermal intraperitoneal chemotherapy with the water extract from Burr parsley (Caucalis platycarpos L.). |
| Q51741261 | Prevention of peritoneal carcinomatosis in mice with combination hyperthermal intraperitoneal chemotherapy and IL-2. |
| Q98727555 | Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal Origin |
| Q73444729 | Primary adenocarcinoma of the appendix; report of a case with ruptured appendix and peritoneal carcinomatosis |
| Q80343931 | Principles of perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis |
| Q50053647 | Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal C |
| Q36758901 | Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). |
| Q67837131 | Problems in abdominal surgery. VI. Intestinal obstruction from peritoneal carcinomatosis |
| Q84190084 | Prognosis of colorectal cancer with peritoneal carcinomatosis: is a new staging necessary? |
| Q103837665 | Prognostic Impact and Utility of Immunoprofiling in the Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC) |
| Q90392289 | Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC |
| Q99713169 | Prognostic Impact of Primary Side and RAS/RAF Mutations in a Surgical Series of Colorectal Cancer with Peritoneal Metastases |
| Q98242182 | Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases |
| Q97549882 | Prognostic Value and Risk Factors of Peritoneal Carcinomatosis Recurrence for Patients with Endometrial Cancer: A Multicenter Study from the FRANCOGYN Group |
| Q95562064 | Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy |
| Q41167062 | Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure |
| Q51742663 | Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. |
| Q90359758 | Prognostic factors for early recurrences following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases |
| Q86061423 | Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database |
| Q83973822 | Prognostic factors in patients with synchronous peritoneal carcinomatosis (PC) caused by a primary cancer of the colon |
| Q104790538 | Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: A systematic review and meta-analysis |
| Q89573385 | Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis |
| Q40496581 | Prognostic factors of intraperitoneal chemotherapy for peritoneal carcinomatosis of gastric cancer: A retrospective study from a single center |
| Q55688974 | Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy. |
| Q51005778 | Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy. |
| Q44969242 | Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy |
| Q24556616 | Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer |
| Q88474320 | Prognostic scores for colorectal cancer with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q91437969 | Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer |
| Q60629613 | Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers |
| Q87256857 | Prognostic similarities and differences in optimally resected liver metastases and peritoneal metastases from colorectal cancers |
| Q38729978 | Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review |
| Q104610357 | Prolonged clinical response with regorafenib administered as second-line therapy in an elderly patient suffering from peritoneal carcinomatosis of colon cancer |
| Q91434582 | Prolonged perioperative thoracic epidural analgesia may improve survival after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A comparative study |
| Q35285436 | Prolonged survival following maximal cytoreductive effort for peritoneal metastases from recurrent granulosa cell tumor of the ovary |
| Q45102427 | Prophylactic and therapeutic continuous hyperthermic peritoneal perfusion for peritoneal metastases of gastric cancer |
| Q72063777 | Prophylaxis and treatment of peritoneal carcinomatosis: Intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles |
| Q40771519 | Prophylaxis of peritoneal carcinomatosis in experimental investigations |
| Q99560181 | Prospective Correlation of the Radiological, Surgical and Pathological Findings in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases - Implications on the Preoperative Estimation of the Peritoneal Cancer Index (PCI) |
| Q47789478 | Prospective Quality of Life Study for Colorectal Cancer Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. |
| Q33931049 | Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases |
| Q91776484 | Prostate Cancer Nonascitic Peritoneal Carcinomatosis After Robot-assisted Laparoscopic Radical Prostatectomy: 3 Case Reports and Review of the Literature |
| Q38281611 | Quality of life after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy for peritoneal carcinomatosis: A systematic review and meta-analysis |
| Q88030224 | Quality of life and cost effectiveness in a randomized trial of patients with colorectal cancer and peritoneal metastases |
| Q48010412 | Quality of life in peritoneal carcinomatosis: a prospective study in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). |
| Q83474834 | Quantitative intra-operative assessment of peritoneal carcinomatosis - a comparison of three prognostic tools |
| Q90689168 | ROS1-rearranged lung adenocarcinoma with peritoneal carcinomatosis on initial presentation |
| Q92132547 | RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis |
| Q36569460 | Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer |
| Q90422779 | Radical treatment of peritoneal carcinomatosis: Times are changing |
| Q92449079 | Radical treatment of peritoneal carcinomatosis: Times are changing |
| Q56967468 | Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer |
| Q79150738 | Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer |
| Q64109947 | Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing r |
| Q89612710 | Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G) |
| Q39836458 | Randomized, blinded comparison of transgastric, transcolonic, and laparoscopic peritoneoscopy for the detection of peritoneal metastases in a human cadaver model |
| Q38988038 | Rapamycin-enhanced mitomycin C-induced apoptotic death is mediated through the S6K1-Bad-Bak pathway in peritoneal carcinomatosis |
| Q33843962 | Rapid onset lung squamous cell carcinoma with prominent peritoneal carcinomatosis and an eosinophilic leukemoid reaction, with coexistence of the BRAF V600E and oncogenic KRAS G12A mutations: A case report |
| Q92511688 | Rapidly Lethal Ruptured Hepatocellular Carcinoma With Disseminated Peritoneal Carcinomatosis on FDG PET/CT |
| Q92178050 | Rare Distant Metastatic Disease of Ovarian and Peritoneal Carcinomatosis: A Review of the Literature |
| Q44702676 | Rare occurrence of bilateral breast and peritoneal metastases from osteogenic sarcoma |
| Q42650614 | Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients |
| Q96341638 | Rate of Peritoneal Carcinomatosis in Resected Stage II and III Colon Cancer |
| Q48270849 | Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model |
| Q98507038 | Ratios of miRNAs in Peritoneal Exosomes are Useful Biomarkers to Predict Tumor Response to Intraperitoneal Chemotherapy in Patients with Peritoneal Metastases from Gastric Cancer |
| Q88443605 | Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016) |
| Q83213515 | Re: peritoneal metastases after laparoscopic nephron-sparing surgery for localized Wilms tumor |
| Q87590400 | Re: recommendations for bowel obstruction with peritoneal carcinomatosis by laval et Al |
| Q38778938 | Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines |
| Q80805495 | Recommendations for general surgeons facing incidental peritoneal carcinomatosis of colorectal origin |
| Q79890258 | Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome |
| Q100758794 | Recurrent Malignant Pheochromocytoma With Unusual Peritoneal Carcinomatosis Detected on 131I-MIBG SPECT/CT |
| Q44090268 | Recurrent Peritoneal Metastases after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer |
| Q85355512 | Recurrent peritoneal carcinomatosis in the scrotum in a patient with a history of mucocele of the appendix |
| Q97587859 | Recurring pediatric anaplastic ependymoma with rare peritoneal carcinomatosis: a case report and hypothesis of mechanism |
| Q33288479 | Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats |
| Q47763947 | Regimens of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer. |
| Q37497357 | Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery |
| Q52917228 | Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators. |
| Q74449898 | Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma |
| Q40558669 | Renal cancer revealed by peritoneal carcinomatosis |
| Q70147058 | Renal cell carcinoma presenting with diffuse peritoneal metastases: CT findings |
| Q95426816 | Reoperation combining re-cytoreductive surgery and re-HIPEC for recurrent peritoneal carcinomatosis |
| Q92064358 | Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases |
| Q47404414 | Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin. |
| Q38174700 | Repeat cytoreductive surgery (CRS) for recurrent colorectal peritoneal metastases: yes or no? |
| Q85640628 | Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes |
| Q92226266 | Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, pha |
| Q86823197 | Reply to letter: "Prevention of peritoneal carcinomatosis from colorectal cancer: a critical issue" |
| Q91729255 | Reply to the Letter to the Editor Regarding "Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy" |
| Q91759247 | Reply to: Inflammatory bowel disease with peritoneal metastases: A complex and extremely variable disease |
| Q88214923 | Reply to: Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016) |
| Q83787337 | Reply to: Use of FDG PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy: some considerations |
| Q50505555 | Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. |
| Q40251206 | Resectability of Peritoneal Carcinomatosis: Learnings from a Prospective Cohort of 533 Consecutive Patients Selected for Cytoreductive Surgery |
| Q36391706 | Resection of peritoneal metastases causing malignant small bowel obstruction |
| Q77887486 | Resection of peritoneal metastases from hepatocellular carcinoma |
| Q45143299 | Resection of peritoneal metastases in patients with hepatocellular carcinoma |
| Q49339342 | Residual tumour less than 0.25 centimetres and positive lymph nodes are risk factors for early relapse in recurrent ovarian peritoneal carcinomatosis treated with cytoreductive surgery, HIPEC and systemic chemotherapy |
| Q60629685 | Results of Systematic Second-Look Surgery in Patients at High Risk of Developing Colorectal Peritoneal Carcinomatosis |
| Q60629647 | Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis |
| Q37583751 | Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer |
| Q89833593 | Retrospective analysis of 18 cases of gastric cancer with peritoneal metastases resulting in successful conversion surgery |
| Q97878954 | Ribociclib therapy in peritoneal carcinomatosis secondary to HER2-negative metastatic breast cancer: A clinical case with a positive outcome |
| Q57178036 | Risk factors for appendiceal and colorectal peritoneal metastases |
| Q96956837 | Risk of Omental Metastases in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases |
| Q87442254 | Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer |
| Q47569210 | Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma |
| Q45908633 | Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125. |
| Q104796592 | Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT |
| Q38555902 | Role of aggressive surgery for peritoneal metastases |
| Q36031340 | Role of ascites adenosine deaminase in differentiating between tuberculous peritonitis and peritoneal carcinomatosis |
| Q46409901 | Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients |
| Q54275039 | Role of conventional chemosensitivity test and tissue biomarker expression in predicting response to treatment of peritoneal carcinomatosis from colon cancer. |
| Q91940870 | Role of diagnostic laparoscopy in patients with suspicion of colorectal peritoneal metastases to evaluate suitability for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy |
| Q34130132 | Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). |
| Q72386236 | Role of macrophages in the host response to Lewis lung peritoneal carcinomatosis |
| Q72051863 | Role of macrophages in the immunotherapy of Lewis lung peritoneal carcinomatosis |
| Q26799152 | Role of multi-modality therapy in peritoneal carcinomatosis and visceral metastasis: a case report and review of the literature |
| Q40314315 | Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer |
| Q69889257 | Role of whole abdominal radiation therapy in the management of endometrial cancer; prognostic importance of factors indicating peritoneal metastases |
| Q45978888 | Routine ureteric stenting before cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in managing peritoneal carcinomatosis from gynecologic malignancies: a single-center experience. |
| Q54322325 | Rt-PCR increases detection of submicroscopic peritoneal metastases in gastric cancer and has prognostic significance. |
| Q75912652 | Ruptured dermoid cyst of the ovary simulating abdominal carcinomatosis; report of case |
| Q72312877 | Safety and efficacy of intraperitoneal injection of etoposide in oil suspension in mice with peritoneal carcinomatosis |
| Q90771211 | Safety and efficacy of transarterial interventional therapy for treatment of hepatocellular carcinoma with peritoneal metastases |
| Q36851100 | Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis |
| Q84768414 | Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer |
| Q90012901 | Safety of coloanal/ileoanal anastomosis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: results of 20 consecutive patients |
| Q50117915 | Safety of extraperitoneal rectal resection and ileo- or colorectal anastomosis without loop ileostomy in patients with peritoneal metastases treated with CRS and HIPEC. |
| Q48532815 | Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC. |
| Q58546674 | Safety of intraperitoneal paclitaxel combined with conventional chemotherapy for colorectal cancer with peritoneal carcinomatosis: a phase I trial |
| Q37805547 | Salvage cytoreduction for chemorefractory ovarian cancer with peritoneal carcinomatosis: a last chance or futile efforts? |
| Q43807749 | Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rate |
| Q39648893 | Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer |
| Q41213346 | Sclerosing mesenteritis mimicking metachronous peritoneal metastases from descending colon adenocarcinoma |
| Q92617817 | Scoring histological regression in peritoneal carcinomatosis: does it count? |
| Q64064235 | Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial |
| Q77643301 | Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features |
| Q87207160 | Second-look surgery plus HIPEC for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Should we resect the initial anastomosis? An observational study |
| Q42324105 | Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Does it really save lives? |
| Q97894909 | Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study |
| Q44199166 | Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction |
| Q37075273 | Secretory TRAIL-Armed Natural Killer Cell-Based Therapy: In Vitro and In Vivo Colorectal Peritoneal Carcinomatosis Xenograft |
| Q39366807 | Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp--/rag2-- mice |
| Q36753448 | Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy |
| Q70318936 | Selective delivery of high levels of mitomycin C to peritoneal carcinomatosis using a new dosage form |
| Q39292965 | Sensation of abdominal pain induced by peritoneal carcinomatosis is accompanied by changes in the expression of substance P and μ-opioid receptors in the spinal cord of mice |
| Q42235262 | Severely calcified peritoneal metastases masquerading as retained barium on CT scan |
| Q93357477 | Short-term outcomes after laparoscopic cytoreductive surgery in patients with limited peritoneal metastases from colorectal cancer |
| Q86075761 | Should isolated peritoneal carcinomatosis from colorectal cancer be sub-classified into stage IVB in era of modern chemotherapy? |
| Q85599953 | Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study |
| Q37498106 | Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality |
| Q91075622 | Signet ring cell features with peritoneal carcinomatosis in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are associated with poor overall survival |
| Q83764549 | Significance of lymph node metastasis in patients with colorectal cancer peritoneal carcinomatosis |
| Q37267412 | Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin |
| Q87032961 | Simultaneous surgical treatment for both colorectal liver metastases and peritoneal carcinomatosis |
| Q90420282 | Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience |
| Q83971389 | Sitilo experience on peritoneal carcinomatosis from colorectal cancer: clinical prognostic features |
| Q86709472 | Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer |
| Q44770840 | Smad interacting protein 1 (SIP1) is associated with peritoneal carcinomatosis in intestinal type gastric cancer |
| Q93734527 | Small intestinal obstruction from peritoneal carcinomatosis |
| Q46973536 | Solitary peritoneal carcinomatosis in prostate cancer |
| Q51753352 | Solitary peritoneal metastases from ductal breast cancer. |
| Q45868914 | Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes |
| Q50177698 | Sonographic detection of peritoneal carcinomatosis: a prospective study of 37 cases |
| Q50183632 | Specific computed virtual chromoendoscopy for detection of peritoneal carcinomatosis: an animal study |
| Q98281046 | Spectral photon-counting CT imaging of colorectal peritoneal metastases: initial experience in rats |
| Q38630275 | Spermatic Cord and Peritoneal Metastases from Unruptured Hepatocellular Carcinoma |
| Q30476956 | Spilled gallstones mimicking peritoneal metastases |
| Q55645006 | Spilled gallstones simulating peritoneal carcinomatosis: A case report and literature review. |
| Q91945979 | Splenosis Mimicking Peritoneal Carcinomatosis |
| Q36314621 | Spontaneous regression of peritoneal carcinomatosis from a rectal cancer |
| Q79795532 | Spontaneous regression of peritoneal carcinomatosis in a borderline ovarian tumour |
| Q38901826 | Staging laparoscopy in gastric cancer to detect peritoneal metastases: A systematic review and meta-analysis |
| Q83569287 | Staging laparoscopy using ALA-mediated photodynamic diagnosis improves the detection of peritoneal metastases in advanced gastric cancer |
| Q53472724 | Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. |
| Q92716708 | Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer |
| Q96773103 | Strategies for 'bloodless' surgery: the experience of cytoreductive surgery for peritoneal carcinomatosis in Jehovah's Witnesses |
| Q91917738 | Strategies for Managing Intraoperative Discovery of Limited Colorectal Peritoneal Metastases |
| Q36090527 | Strategies for the prevention and treatment of peritoneal carcinomatosis from gastrointestinal cancer |
| Q30239825 | Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer |
| Q57904713 | Study of T Lymphocytes Infiltrating Peritoneal Metastases in Advanced Ovarian Cancer |
| Q92433823 | Successful conversion surgery for unresectable pancreatic cancer with peritoneal metastases after neoadjuvant albumin-bound paclitaxel and gemcitabine chemotherapy: case report and literature review |
| Q38017942 | Summary of current therapeutic options for peritoneal metastases from colorectal cancer |
| Q68051525 | Superior mesenteric arterial infusion chemotherapy in patient with both peritoneal carcinomatosis and liver metastasis |
| Q86933947 | Suppression of Peritoneal Metastases by Expression of Murine Endostatin cDNA |
| Q28207702 | Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin |
| Q47597474 | Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cells by overexpression of AP-2alpha |
| Q37422391 | Surgery and intracavitary chemotherapy for peritoneal carcinomatosis from colorectal origin. |
| Q43845074 | Surgery as adjuvant therapy? The treatment of peritoneal metastases from gastrointestinal malignancy |
| Q73063070 | Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study |
| Q36566245 | Surgery for peritoneal carcinomatosis from colorectal origin: techniques and limitations |
| Q83371433 | Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis |
| Q37145798 | Surgical cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from the appendix. |
| Q83857849 | Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: an evaluation of 46 consecutive patients |
| Q34107863 | Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. |
| Q92301350 | Surgical management for peritoneal carcinomatosis of appendiceal origin with a high-tumor burden |
| Q38058707 | Surgical management of colorectal peritoneal metastases: treatment and outcomes compared with hepatic metastases. |
| Q80212968 | Surgical management of peritoneal carcinomatosis: from clinical research to standard of care |
| Q41828967 | Surgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection |
| Q80180244 | Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis (Br J Surg 2006; 93: 1530-1535) |
| Q37798985 | Surgical treatment for peritoneal carcinomatosis from gastric cancer |
| Q78596786 | Surgical treatment of disseminated peritoneal metastases from urological cancer: results from a prospective study |
| Q38025112 | Surgical treatment of peritoneal carcinomatosis from gastric cancer |
| Q81596318 | Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas |
| Q45019679 | Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture |
| Q38163913 | Surgical treatment of peritoneal carcinomatosis: current treatment modalities |
| Q39493979 | Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin |
| Q92439974 | Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience |
| Q100462984 | Survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A systematic review and discussion of latest controversies |
| Q37158542 | Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin |
| Q37373079 | Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score-matched analysis |
| Q38950004 | Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based study. |
| Q92617822 | Survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from gastric cancer: a systematic review |
| Q95569756 | Survival prognostic factors in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy: a single institution experience |
| Q80143575 | Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis |
| Q85312875 | Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study |
| Q90319513 | Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer |
| Q91532703 | Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment? |
| Q85603495 | Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre |
| Q90912261 | Synchronous peritoneal carcinomatosis from a buccal squamous cell carcinoma: a case report focusing on possible metastatic mechanisms and novel therapeutic modalities |
| Q47607099 | Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon |
| Q37699783 | Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicity |
| Q36818968 | Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer |
| Q29994639 | Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis |
| Q92541077 | Systematic review of published literature on oxaliplatin and mitomycin C as chemotherapeutic agents for hyperthermic intraperitoneal chemotherapy in patients with peritoneal metastases from colorectal cancer |
| Q36571925 | Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. |
| Q96643032 | Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial |
| Q102063287 | Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A case report of a multimodal treatment for peritoneal metastases of pancreatic origin |
| Q36882835 | Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. |
| Q36882840 | Systemic chemotherapy in patients with peritoneal carcinomatosis from non colorectal origin |
| Q98190127 | Systemic immune-inflammation index (SII): A More Promising Inflammation-Based Prognostic Marker for Patients with synchronic colorectal peritoneal carcinomatosis |
| Q36388283 | Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin. |
| Q82794174 | TGF-β1 induces peritoneal fibrosis by activating the Smad2 pathway in mesothelial cells and promotes peritoneal carcinomatosis |
| Q35678699 | Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival |
| Q92358099 | Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells |
| Q38731251 | Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles. |
| Q89893291 | Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases |
| Q38350493 | Targeting the peritoneum with novel drug delivery systems in peritoneal carcinomatosis: a review of the literature |
| Q69662591 | Technical aspects of intraperitoneal chemotherapy in abdominal carcinomatosis |
| Q86991411 | The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) |
| Q92020018 | The Accuracy of Multidetector Computed Tomography and Laparoscopy in the Prediction of Peritoneal Carcinomatosis Index Score in Primary Ovarian Cancer: Terminology Issues |
| Q39560542 | The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer. |
| Q41822330 | The Effect of Deep X-rays on the Peritoneal Metastases of an Ovarian Carcinoma. |
| Q51608240 | The Impact of Tunneled Catheters for Ascites and Peritoneal Carcinomatosis on Patient Rehospitalizations. |
| Q89629930 | The Pathologic Peritoneal Cancer Index (PCI) Strongly Differs From the Surgical PCI in Peritoneal Metastases Arising From Various Primary Tumors |
| Q41614934 | The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study. |
| Q64254982 | The Role of Laparoscopy and the Value of Peritoneal Carcinomatosis Index in Patients with Intra-Abdominal Malignancies who are Scheduled to Laparotomy |
| Q39036955 | The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review |
| Q92233380 | The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database Analysis |
| Q95561079 | The Surgical Management of Peritoneal Carcinomatosis of Colorectal Origin |
| Q40155200 | The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer |
| Q34624096 | The Trifunctional Antibody Catumaxomab in Treatment of Malignant Ascites and Peritoneal Carcinomatosis |
| Q91789638 | The Validity of Registered Synchronous Peritoneal Metastases from Colorectal Cancer in the Danish Medical Registries |
| Q93010766 | The Value of Indocyanine Green (ICG) Fluorescence for the Identification of Peritoneal Carcinomatosis |
| Q92122639 | The accuracy of multi-detector computed tomography and laparoscopy in the prediction of peritoneal carcinomatosis index score in primary ovarian cancer |
| Q39556474 | The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer |
| Q39674041 | The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model. |
| Q57175224 | The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI) |
| Q78336618 | The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma |
| Q90373650 | The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy |
| Q46422975 | The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat. |
| Q88446001 | The emerging roles of functional imaging in ovarian cancer with peritoneal carcinomatosis |
| Q37945471 | The impact of peritoneal metastases in epithelial ovarian cancer with positive nodes |
| Q58552047 | The impact of radiological retroperitoneal lymphadenopathy on survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases |
| Q89813439 | The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single |
| Q39226316 | The importance of gender in patients with peritoneal metastases of appendiceal origin treated by cytoreduction and intraperitoneal chemotherapy: an analysis of 257 consecutive patients from an Australian centre |
| Q92605075 | The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q43120613 | The influence of ovarian cancer induced peritoneal carcinomatosis on the pharmacokinetics of albendazole in nude mice |
| Q40004701 | The long-term impact of hyperthermic intraperitoneal chemotherapy on survivors treated for peritoneal carcinomatosis: a cross-sectional study. |
| Q79870026 | The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer |
| Q46596474 | The modified Glasgow prognostic score for early mortality in patients with synchronous peritoneal carcinomatosis from colorectal cancer |
| Q35138981 | The molecular biology of peritoneal carcinomatosis from gastrointestinal cancer. |
| Q52986573 | The presence of cardiophrenic angle lymph nodes is not an indicator of peritoneal carcinomatosis from colorectal cancer on MDCT: Results of a case-control study. |
| Q66978549 | The results of surgical treatment of bowel obstruction caused by peritoneal carcinomatosis |
| Q38832409 | The role of "closed abdomen" hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience |
| Q38269169 | The role of HIPEC in the treatment of peritoneal carcinomatosis from gastric cancer: between lights and shadows. |
| Q45209433 | The role of VEGFR-2 expression in outcomes and survival of patients with peritoneal carcinomatosis from appendiceal cancer. |
| Q84268183 | The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments |
| Q84437635 | The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis |
| Q102055816 | The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: a systematic review including evidence from Japan |
| Q84910382 | The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer |
| Q36987207 | The role of laparoscopy in the diagnosis and treatment of peritoneal carcinomatosis: a case report |
| Q81795239 | The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy |
| Q77951668 | The role of peritoneal immunity and the tumour-bearing state on the development of wound and peritoneal metastases after laparoscopy |
| Q93917167 | The role of peritoneal immunity and the tumour-bearing state on the development of wound and peritoneal metastases after laparoscopy |
| Q92009865 | The role of single-incision laparoscopic peritoneal exploration in the management of patients with peritoneal metastases |
| Q92037020 | The role of the peritoneal microenvironment in the pathogenesis of colorectal peritoneal carcinomatosis |
| Q95927630 | The structural effect of high intensity ultrasound on peritoneal tissue: a potential vehicle for targeting peritoneal metastases |
| Q38201470 | The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art. |
| Q46783635 | The treatment of peritoneal carcinomatosis in elderly patients. |
| Q44667185 | The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study |
| Q48901514 | The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study |
| Q104615281 | The utility of high-mobility group A2 overexpression for predicting the prognosis of gastric cancer patients and its contribution to poor prognosis via chemoresistance and the propensity for the occurrence of carcinomatosis peritonei |
| Q38764964 | The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133 |
| Q93080075 | The volume-time index (VTI) is prognostic in patients with colorectal cancer peritoneal metastases undergoing cytoreductive surgery and intraperitoneal chemotherapy |
| Q36387694 | Therapeutic Efficacy of Alpha-RIT Using a (213)Bi-Anti-hCD138 Antibody in a Mouse Model of Ovarian Peritoneal Carcinomatosis |
| Q35730208 | Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept |
| Q74643552 | Therapeutic effects of 5-fluorouracil microspheres on peritoneal carcinomatosis induced by Colon 26 or B-16 melanoma in mice |
| Q92618034 | Therapeutic efficacy of systemic therapy for colorectal peritoneal carcinomatosis: Surgeon's perspective |
| Q43524473 | Therapeutic innovations in the management of peritoneal carcinomatosis from digestive origin: cytoreductive surgery and intraperitoneal chemotherapy |
| Q79778343 | Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis |
| Q37971749 | Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer |
| Q90698081 | Therapy and Prophylaxis of Peritoneal Metastases from Colorectal Cancer |
| Q45871906 | Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses |
| Q47593277 | Therapy of peritoneal carcinomatosis of human colon cancer xenografts with yttrium 90-labeled anti-carcinoembryonic antigen antibody ZCE025. |
| Q35148769 | Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers |
| Q37745946 | Thinking beyond peritoneal carcinomatosis: imaging spectrum of unusual disseminated peritoneal entities |
| Q40255257 | Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy |
| Q79378644 | Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal origin |
| Q49545597 | Total Mesenteric Peritonectomy for Peritoneal Metastases (with video). |
| Q102386024 | Total Pelvic Exenteration, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Rectal Cancer with Associate Peritoneal Metastases: Surgical Strategies to Optimize Safety |
| Q47383911 | Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy for the surgical palliation of mucinous peritoneal carcinomatosis from non-gynecologic cancer |
| Q91398507 | Total pelvic exenterative surgery in patients with peritoneal metastases from appendiceal neoplasms. A case series of 2 patients |
| Q92045122 | Total pelvic peritonectomy for ovarian cancer with extensive peritoneal carcinomatosis in pelvic cavity |
| Q44199787 | Totally implantable systems in colorectal tumors. The locoregional chemotherapy of hepatic and peritoneal metastases |
| Q43421690 | Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients |
| Q83656036 | Towards randomized trials of cytoreductive surgery using peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis |
| Q68250353 | Toxic reduction and superior therapeutic effects on peritoneal carcinomatosis of etoposide particles suspended in oil in mice |
| Q84259351 | Transgastric NOTES for the detection of peritoneal carcinomatosis: more targets needed for a thorough evaluation |
| Q56999369 | Transvaginal sonographic features of peritoneal carcinomatosis |
| Q52814844 | Transvaginal ultrasound (TVUS)-guided biopsy is safe and effective in diagnosing peritoneal carcinomatosis and recurrent pelvic malignancy. |
| Q73793632 | Transvaginal versus transrectal ultrasonography in the diagnosis of peritoneal carcinomatosis |
| Q96815833 | Treatment Outcome of Resection of Disseminated Peritoneal Metastases from Colorectal Cancer |
| Q35563233 | Treatment and prevention of peritoneal carcinomatosis from colorectal cancer |
| Q38158998 | Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale. |
| Q52578760 | Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. |
| Q35721069 | Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. |
| Q88558404 | Treatment of colorectal peritoneal metastases requires multidisciplinary efforts |
| Q35761199 | Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity. |
| Q37895575 | Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity |
| Q35109585 | Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab |
| Q47130298 | Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study |
| Q55155497 | Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy. |
| Q77401741 | Treatment of liver metastases with moderate peritoneal carcinomatosis by hepatectomy and cytoreductive surgery followed by immediate post-operative intraperitoneal chemotherapy: feasibility and preliminary results |
| Q55318427 | Treatment of patients with peritoneal metastases from gastric cancer. |
| Q41134438 | Treatment of peritoneal carcinomatosis by continuous hyperthermic peritoneal perfusion with cisplatin. |
| Q79151427 | Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity |
| Q72802467 | Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts |
| Q33455875 | Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells |
| Q80790226 | Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin |
| Q45388842 | Treatment of peritoneal carcinomatosis from breast cancer by maximal cytoreduction and HIPEC: a preliminary report on 5 cases. |
| Q71636579 | Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intraperitoneal chemotherapy |
| Q45747557 | Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and HIPEC: preliminary results in highly selected patients |
| Q82791754 | Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years |
| Q45255751 | Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy |
| Q37006560 | Treatment of peritoneal carcinomatosis from colorectal cancer with cytoreductive surgery and perioperative intraperitoneal chemotherapy: state of the art and future prospects |
| Q44880937 | Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials |
| Q95572273 | Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) |
| Q36987501 | Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals |
| Q36090050 | Treatment of peritoneal carcinomatosis in gastric cancers |
| Q81068411 | Treatment of peritoneal carcinomatosis in patients with digestive cancers with combination of intraperitoneal hyperthermia and mitomycin C |
| Q38493893 | Treatment of peritoneal carcinomatosis of colorectal origin |
| Q79480948 | Treatment of peritoneal carcinomatosis using carboplatin-loaded hydroxyapatite particles |
| Q92618056 | Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy - PIPAC-OPC2 |
| Q37796277 | Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. |
| Q39406537 | Treatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer. |
| Q52167494 | Treatment of peritoneal carcinomatosis with intent to cure. |
| Q38879821 | Treatment of peritoneal carcinomatosis with intraperitoneal administration of Ad-hARF. |
| Q47234024 | Treatment of peritoneal carcinomatosis with photodynamic therapy: Systematic review of current evidence |
| Q26783662 | Treatment of peritoneal metastases from colorectal cancer |
| Q38787018 | Treatment of peritoneal metastases from small bowel adenocarcinoma |
| Q73125898 | Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management |
| Q60629725 | Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer |
| Q24796110 | Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide |
| Q45027842 | Treatment outcomes of systemic chemotherapy for peritoneal carcinomatosis arising from gastric cancer with no measurable disease: retrospective analysis from a single center |
| Q83143671 | Treatment results of peritonectomy combined with perioperative chemotherapy for colorectal cancer-patients with peritoneal carcinomatosis |
| Q54768331 | Treatment with endotoxins of peritoneal carcinomatosis induced by colon tumor cells in the rat. |
| Q40764258 | Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters |
| Q45730190 | Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis |
| Q41437643 | Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands |
| Q88598852 | Tuberculosis Mimicking Disseminated Peritoneal Carcinomatosis of a Sigmoid Carcinoma |
| Q93090312 | Tuberculous abdominal cocoon mimicking peritoneal carcinomatosis |
| Q34192552 | Tuberculous peritonitis developing in a case of documented peritoneal carcinomatosis |
| Q90979542 | Tuberculous peritonitis mimicking carcinomatosis peritonei: CT findings and histopathologic correlation |
| Q68460564 | Tuftsin increases survival in murine peritoneal carcinomatosis |
| Q92805515 | Tumor Sidedness Is Associated with Survival in Patients with Synchronous Colorectal Peritoneal Carcinomatosis |
| Q92318944 | Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis |
| Q48102763 | Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas. |
| Q92533051 | Twenty-year survival of gastric cancer with peritoneal metastases using long-term normothermic intraperitoneal 5-fluorouracil and systemic mitomycin C: A case report |
| Q90357836 | Two-photon images reveal unique texture features for label-free identification of ovarian cancer peritoneal metastases |
| Q35590698 | Two-step synthesis of galactosylated human serum albumin as a targeted optical imaging agent for peritoneal carcinomatosis |
| Q90436683 | Type I IFN, Ly6C+ cells, and phagocytes support suppression of peritoneal carcinomatosis elicited by a TLR and CLR agonist combination |
| Q88262812 | Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer |
| Q51481047 | Unresectable peritoneal carcinomatosis from colorectal cancer: a single center experience. |
| Q53448819 | Unusual adrenal metastasis and abdominal carcinomatosis secondary to Hurthle cell carcinoma of the thyroid. |
| Q44001138 | Unusual survival for more than 2 years with peritoneal metastases of gastric cancer |
| Q26865727 | Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer |
| Q38319703 | Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors |
| Q90156646 | Upfront debulking surgery versus interval debulking surgery for advanced tubo-ovarian high-grade serous carcinoma and diffuse peritoneal metastases treated with peritonectomy procedures plus HIPEC |
| Q44700965 | Uptake of 5-fluorouracil (5-FU) in peritoneal metastases in relation to the route of drug administration and tumour debulking surgery. an autoradiographic study in the rat. |
| Q80739561 | Uptake of Tc-99m methylene diphosphonate in peritoneal metastases from breast cancer |
| Q30383569 | Urachal Carcinoma with Choroidal, Lung, Lymph Node, Adrenal, Mammary, and Bone Metastases and Peritoneal Carcinomatosis Showing Partial Response after Chemotherapy Treatment with a Modified Docetaxel, Cisplatin and 5-Fluorouracil Regimen |
| Q44219208 | Urological procedures in patients with peritoneal carcinomatosis of colorectal cancer treated with HIPEC: morbidity and survival analysis |
| Q52970913 | Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue. |
| Q82267553 | Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy |
| Q51217628 | Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian Cancer. |
| Q57547078 | Use of hyperthermia versus normothermia during intraperitoneal chemoperfusion with oxaliplatin for colorectal peritoneal carcinomatosis: A propensity score matched analysis |
| Q36416973 | Use of hyperthermic intraperitoneal chemotherapy (HIPEC) in management of peritoneal carcinomatosis from colorectal origin |
| Q85385453 | Usefulness of dual-time point imaging after carbonated water for the fluorodeoxyglucose positron emission imaging of peritoneal carcinomatosis in colon cancer |
| Q74522357 | Uterine adenocarcinoma with abdominal carcinomatosis in a beluga whale |
| Q99577943 | Utility of fluorescence-guided surgery in the laparoscopic approach of peritoneal carcinomatosis: two cases in our center |
| Q50068228 | Validation of diagnostic methods for peritoneal carcinomatosis secondary to ovarian cancer. CT-scan, PET-CT or laparoscopy, what is the best? |
| Q85355207 | Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis |
| Q85651879 | Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis (Br J Surg 2013; 100: 285-292) |
| Q47680689 | Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma |
| Q36706378 | Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. |
| Q96587942 | Visual PET/CT scoring of mesenteric fdg uptake to differentiate between tuberculous peritonitis and peritoneal carcinomatosis |
| Q95932669 | WJOG10517G: a multicenter Phase II study of mFOLFOX6 in gastric cancer patients with severe peritoneal metastases |
| Q33440794 | Waldenström's macroglobulinemia masquerading as ovarian cancer with peritoneal carcinomatosis, ascites, and elevated CA-125. |
| Q60919176 | Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases |
| Q42609314 | Women with peritoneal carcinomatosis of unknown origin: Efficacy of image-guided biopsy to determine site-specific diagnosis. |
| Q94451591 | YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition |
| Q51737643 | Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer. |
| Q36696611 | ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer. |
| Q90205574 | [A Case of Peritoneal Metastases after Radiofrequency Ablation for Liver Metastasis from a Pancreatic Neuroendocrine Tumor] |
| Q79363584 | [A case of duodenal carcinoma with massive peritoneal carcinomatosis complicating a pulmonary embolism] |
| Q95514519 | [A case of peritoneal carcinomatosis due to recurrence of primary adenocarcinoma of the ureter treated with weekly paclitaxel] |
| Q80151710 | [A case of scirrhous gastric cancer with peritoneal metastases successfully treated by combined chemotherapy of biweekly paclitaxel and TS-1 followed by curative resection] |
| Q84821304 | [A case of small intestinal cancer with peritoneal metastases treated with FOLFOX regimen] |
| Q73742776 | [A case of small renal cell carcinoma (diameter 1.5 cm) presenting with a large amount of ascites due to peritoneal carcinomatosis] |
| Q79874422 | [A case of widespread ileal stenosis caused by metastatic disseminated peritoneal carcinomatosis from lung cancer resected 8 years previously] |
| Q80548674 | [A clinical significance of peritoneal carcinomatosis to recurrent colorectal cancer with ileus] |
| Q81561507 | [A false peritoneal carcinomatosis] |
| Q85788890 | [A long-term survivor of colorectal cancer associated with multiple liver metastases and peritoneal carcinomatosis treated through a multidisciplinary approach] |
| Q68811516 | [Adoptive immunotherapy against peritoneal metastases from stomach cancer--application of regional lymph node lymphocytes] |
| Q80004068 | [Atypical presentation of angiomiolypoma in a patient with peritoneal metastases from ovarian cancer: a case report] |
| Q91588391 | [CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PERITONEAL CARCINOMATOSIS OF COLORECTAL ORIGIN - FIRST 100 CASES] |
| Q74592936 | [Calcified peritoneal metastases of an osteoid gastric carcinoma] |
| Q84026670 | [Calcifying cystic fibrous tumour. A rare form of benign peritoneal carcinomatosis] |
| Q74397391 | [Chemotherapeutic management of peritoneal carcinomatosis] |
| Q53664879 | [Clinical and diagnostic significance of abdominal CT for peritoneal metastases in patients with primary gastric cancer]. |
| Q73018765 | [Clinical conference; cancer of the stomach; peritoneal metastases and fibrothorax] |
| Q80276078 | [Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy] |
| Q80004083 | [Collateral effects of intraoperative hyperthermic chemotherapy in peritoneal carcinomatosis] |
| Q79876298 | [Combined cytoreductive surgery and intraoperative hyperthermic chemo-perfusion for peritoneal carcinomatosis: methods, postoperative features and end results] |
| Q84694034 | [Comparison of (18)F-FDG PET-CT and abdomen enhancement CT in diagnosing peritoneal metastases] |
| Q52901165 | [Current role of x-ray computed tomographic test in the detection of lesions of peritoneal carcinomatosis] |
| Q83938904 | [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy associated toxicity in treatment of peritoneal carcinomatosis] |
| Q95471778 | [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal and appendiceal origin] |
| Q82719897 | [Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature] |
| Q78347526 | [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis] |
| Q58559920 | [Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat peritoneal carcinomatosis from gastric cancer: a clinical study of 110 patients] |
| Q95507615 | [Efficacy of oxaliplatin-based chemotherapy in Stage IV colorectal cancer patients with peritoneal carcinomatosis] |
| Q68120510 | [Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats] |
| Q70476458 | [Experimental studies on continuous hyperthermic peritoneal perfusion in the treatment for peritoneal metastases of cancer] |
| Q71649681 | [Experimental study of cisplatin microspheres incorporated in polylactic acid and polyethylene glycol acid on peritoneal carcinomatosis in rats] |
| Q95590194 | [Experimental technology of chemoperfusion treatment for abdominal carcinomatosis in ovarian cancer] |
| Q90013632 | [Factors affecting the survival of patients with peritoneal carcinomatosis of colorectal origin] |
| Q93372807 | [French comment on article Impact of peritoneal carcinomatosis on clinical outcomes of patients receiving self-expandable metal stents for malignant colorectal obstruction] |
| Q84186632 | [Gliomatosis peritonei, an unusual abdominal carcinomatosis: report of two cases] |
| Q72362390 | [Home chemotherapy for peritoneal carcinomatosis] |
| Q95471891 | [Hyperthermic intraperitoneal chemotherapy as a new way of peritoneal metastases treatment] |
| Q81666427 | [Hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis arising from gastric cancer] |
| Q73769340 | [Indications for integrated surgical treatment of peritoneal carcinomatosis of colorectal origin: experience of the Italian Society of Locoregional Integrated Therapy in Oncology] |
| Q52027555 | [Integrated treatment of peritoneal carcinomatosis: preliminary experience]. |
| Q73976478 | [Intestinal obstruction and peritoneal carcinomatosis after endoscopic resection of transitional carcinoma of urinary bladder] |
| Q70795998 | [Intestinal obstruction caused by peritoneal carcinomatosis due to signet ring cell carcinoma of the breast] |
| Q73460254 | [Intestinal obstruction secondary to peritoneal carcinomatosis after iatrogenic perforation during TUR for transitional cell carcinoma of the bladder] |
| Q95486533 | [Intraoperative intraperitoneal chemoperfusion treatment with cisplatin and dioxadet on a model of peritoneal carcinomatosis in ovarian cancer: safety and efficacy evaluation] |
| Q71649676 | [Intraperitoneal administration of carboplatin loaded alpha-tricalcium phosphate (alpha-TCP) particles in rats bearing abdominal carcinomatosis] |
| Q72926532 | [Intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers] |
| Q50781336 | [Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients]. |
| Q93609130 | [Intraperitoneal cisplatin in peritoneal carcinomatosis patients] |
| Q73459177 | [Intraperitoneal cisplatin plus epinephrine and surgical debulking for the treatment of advanced peritoneal carcinomatosis in the rat] |
| Q72639455 | [Intraperitoneal hyperthermic chemotherapy (IPHC), a promising treatment of peritoneal carcinomatosis] |
| Q93623497 | [Is the excision of peritoneal metastases of leiomyosarcoma justified? Comments on 2 cases] |
| Q74533370 | [Isolated peritoneal metastases from an lobular infiltrating breast carcinoma. Value of laparoscopy] |
| Q77346297 | [Laparoscopic discovery of disseminated peritoneal leiomyomatosis closely resembling metastatic peritoneal carcinomatosis] |
| Q72831342 | [Late ileal and peritoneal metastases of renal adenocarcinoma disclosed by occlusion] |
| Q80548655 | [Long-term results of peritonectomy on the patients with peritoneal carcinomatosis] |
| Q95490268 | [Management of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy] |
| Q88361308 | [Microscopic peritoneal metastases of epithelial ovarian cancers. Clinical relevance, diagnostic and therapeutic tools] |
| Q91596142 | [Multi-Look Staging Laparoscopy and Conversion Surgery for Gastric Cancer with Peritoneal Metastases] |
| Q77405810 | [New philosophy in the treatment of peritoneal carcinomatosis of gastrointestinal origin] |
| Q81384880 | [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy] |
| Q53072590 | [Novel approved form of treatment for colonic cancer with peritoneal metastases - radicality-aimed surgery combined with hyperthermic intraperitoneal chemotherapy]. |
| Q85825411 | [Opportunities of intraoperative hyperthermic perfusion application in treatment of peritoneal carcinomatosis] |
| Q89183873 | [PIPAC and HIPEC-competing or supplementary therapeutic procedures for peritoneal metastases] |
| Q85858297 | [PIPAC--Pressurized intraperitoneal aerosol chemotherapy. A novel treatment for peritoneal carcinomatosis] |
| Q79926599 | [Pathologic and anatomic evidence of peritoneal metastases] |
| Q53307304 | [Peritoneal AA amyloidosis simulating peritoneal carcinomatosis: a case report]. |
| Q84523047 | [Peritoneal carcinomatosis after robotic-assisted radical cystectomy] |
| Q82987087 | [Peritoneal carcinomatosis due to ocular melanoma] |
| Q53135411 | [Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125]. |
| Q58659719 | [Peritoneal carcinomatosis of colorectal origin. An ethical problem today, a legal problem in the future] |
| Q85948684 | [Peritoneal carcinomatosis of unknown origin] |
| Q73123618 | [Peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemohyperthermia] |
| Q77773952 | [Peritoneal carcinomatosis with elevated adenosine deaminase (ADA) in ascitic fluid] |
| Q84384415 | [Peritoneal carcinomatosis: diagnosis and therapeutics in 2009] |
| Q78302780 | [Peritoneal carcinomatosis: new strategies for more efficacious treatment] |
| Q69168016 | [Peritoneal carcinomatosis: study of the tumor of origin] |
| Q55462239 | [Peritoneal metastases of medulloblastoma due to placement of ventriculoperitoneal shunt in an adult patient]. |
| Q85622912 | [Peritoneal tumor pathology - case no. 6: major histologic colloid response of colorectal peritoneal carcinomatosis after induction treatment] |
| Q52027551 | [Peritonectomy and chemohyperthermia in the treatment of peritoneal carcinomatosis: learning curve]. |
| Q73907638 | [Possibility of alpha-tricalcium phosphate (alpha-TCP) particles as a drug carrier for treatment of abdominal carcinomatosis] |
| Q80328811 | [Preliminary experience with hyperthermic intraperitoneal chemo-perfusion with oxaliplatin for the treatment of peritoneal carcinomatosis due to colorectal carcinoma] |
| Q90699097 | [Pressurised intraperitoneal aerosol chemotherapy (PIPAC) for the treatment of peritoneal metastases] |
| Q53664462 | [Pressurized intraperitoneal aerosol chemotherapy (PIPAC): a new way of administration in peritoneal carcinomatosis of ovarian cancer]. |
| Q68769168 | [Prevention of peritoneal carcinomatosis recurrence with a prostaglandin synthesis inhibitor, indomethacin] |
| Q82296124 | [Principles of the treatment of peritoneal carcinomatosis due to colorectal cancer. Current review and update] |
| Q71649559 | [Prophylaxis of peritoneal carcinomatosis with intraperitoneal administration of cell-adhesion inhibitor, in mice] |
| Q73711820 | [Prospective randomized trial of prophylaxis of postoperative peritoneal carcinomatosis of advanced gastric cancer: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles] |
| Q57150552 | [Protocol for the examination of surgical specimens from patients with peritoneal carcinomatosis originating in ovary, fallopian tube and peritoneum] |
| Q83393453 | [Rationale for perioperative chemotherapy treatment in peritoneal carcinomatosis] |
| Q79314478 | [Resectional treatment of peritoneal carcinomatosis followed by intraperitoneal chemotherapy, practical aspects] |
| Q78578727 | [Small intestinal lymphatic vessels in peritoneal carcinomatosis in man] |
| Q73769400 | [Staging videolaparoscopy of peritoneal carcinomatosis] |
| Q95372980 | [Study of introperitoneal hyperthermic perfusion chemotherapy combined with systemic neoadjuvent chemotherapy in treatment of gastric cancer patients with peritoneal carcinomatosis] |
| Q73730427 | [Study of the toxicity and results of intraperitoneal hyperthermic chemotherapy in 28 patients with peritoneal carcinomatosis] |
| Q67954651 | [Superior mesenteric arterial infusion chemotherapy against intestinal obstruction caused by peritoneal carcinomatosis] |
| Q81773967 | [Surgery for gastric carcinoma in patients with high risk of peritoneal metastases] |
| Q79427855 | [Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin] |
| Q83168328 | [Surgical management of peritoneal carcinomatosis from colorectal cancer] |
| Q81729437 | [Surgical treatment of peritoneal carcinomatosis with reduction surgery and perioperative chemotherapy] |
| Q80606680 | [Surgical treatment of peritoneal carcinomatosis] |
| Q81039639 | [Surgical treatment of peritoneal carcinomatosis] |
| Q89424650 | [Surgical treatment of peritoneal metastases from gynecological primary tumors] |
| Q57162967 | [Surgical treatment of peritoneal metastases of colorectal cancer] |
| Q52805995 | [Surgical treatment of peritoneal metastases of gastric cancer]. |
| Q52918186 | [The Significance and Limitations of Curative Resection for Peritoneal Metastases of Colorectal Cancer]. |
| Q73144585 | [The effect of intra-abdominal temperature on the tissue and tumor diffusion of intraperitoneal cisplatin in a model of peritoneal carcinomatosis in rats] |
| Q81016415 | [The new therapies of the peritoneal carcinomatosis should induce new surgical attitudes] |
| Q85840103 | [The role of intraperitoneal macrophages in the progression of peritoneal carcinomatosis from gastric cancer] |
| Q93041311 | [The status analysis of diagnosis and treatment of synchronous peritoneal carcinomatosis from colorectal cancer in China: a report of 1 003 cases in 16 domestic medical centers] |
| Q68604181 | [Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia with mitomycin C. Initial experience] |
| Q81553003 | [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy] |
| Q85220339 | [Treatment of peritoneal carcinomatosis of gastro-intestinal origin--a retrospective study of 203 cases] |
| Q73130893 | [Treatment of peritoneal carcinomatosis of non-gynecological origin] |
| Q50516032 | [Treatment of peritoneal carcinomatosis using complete excision and intraperitoneal chemohyperthermia. A phase I-II study defining the best technical procedures] |
| Q84068643 | [Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy] |
| Q95385498 | [Treatment of peritoneal carcinomatosis with pressurized intraperitoneal aerosol chemotherapy] |
| Q80573497 | [Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications] |
| Q83020396 | [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up] |
| Q72034370 | [Treatment with butyrate/IL-2 combination in peritoneal carcinomatosis of colonic origin] |
| Q45960441 | [Two advanced gastric cancer cases with peritoneal metastases successfully treated by s-1/paclitaxel combination therapy]. |
| Q83461814 | [Urinary tract surgery in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy] |
| Q53641248 | [Use of absorbable fibrin sealant patch to strengthen the gastrointestinal anastomosis performed on patients with peritoneal carcinomatosis treated with intention to cure by debulking surgery and intraoperative hyperthermic intraperitoneal chemother |
| Q82554948 | [Value of peritoneoscopy via natural orifice transluminal endoscopic surgery in the diagnosis of peritoneal carcinomatosis] |
| Category:Peritoneal carcinomatosis | wikimedia | |
| Catalan (ca / Q7026) | Carcinomatosi peritoneal | wikipedia |
| Peritonealkarzinose | wikipedia | |
| Peritoneal carcinomatosis | wikipedia | |
| Carcinomatosis peritoneal | wikipedia | |
| Carcinose péritonéale | wikipedia |
Search more.